Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certified Pharmacy Executive Leader
Digital Health & Informatics
Diversity, Equity and Inclusion
Health & Wellness
Opioids & Pain Management
Sterile Compounding
Student Posters
Home
Student Posters
All Days
Mon, Dec 9
Tue, Dec 10
Student Posters
Type here to filter the list
Monday, December 9, 2024
10:45 AM - 11:45 AM
(2-001) Short-term continuous glucose monitoring and its impact on pharmacist-led diabetes medication management and blood glucose levels
Favorite
10:45 AM - 11:45 AM
(2-002) A cross-sectional survey of Alabama community pharmacist’s intentions and perceived barriers regarding fentanyl test strip provision.
Favorite
10:45 AM - 11:45 AM
(2-003) Assessment of Efficacy and Adverse Reactions in High-Dose Diltiazem Infusions for Atrial Fibrillation
Favorite
10:45 AM - 11:45 AM
(2-004) Comparing Prescription Drug Monitoring Program Perceptions and Usage Between Medical and Pharmacy Professionals: Impact of an Interdisciplinary Workshop
Favorite
10:45 AM - 11:45 AM
(2-005) Evaluation of Adverse Event Reporting of Sotagliflozin to the U.S. Food and Drug Administration
Favorite
10:45 AM - 11:45 AM
(2-006) Evaluation of Appropriate Oral Anticoagulation Use in Patients with Atrial Fibrillation
Favorite
10:45 AM - 11:45 AM
(2-007) Assessment of Alabama Prescribers’ Perceptions of Pharmacogenomics
Favorite
10:45 AM - 11:45 AM
(2-008) Resident Perceptions of Migraine Management and Interventions to Improve Care
Favorite
10:45 AM - 11:45 AM
(2-009) Evaluation of Time to Clevidipine Discontinuation When Utilizing Various Oral Antihypertensive Agents in Patients Presenting with Hemorrhagic Stroke
Favorite
10:45 AM - 11:45 AM
(2-010) Effects of Diabetes Camps/Conferences on Self-reported Perceived Stigma and Discrimination in Youth with Type 1 Diabetes
Favorite
10:45 AM - 11:45 AM
(2-011) Retrospective Review of Treatment Patterns for Hyperkalemia Management in a Community Hospital Setting
Favorite
10:45 AM - 11:45 AM
(2-012) Development of the Medication Education for Dementia Support (MEDS) Toolkit for Community Pharmacy Collaboration with Home Health
Favorite
10:45 AM - 11:45 AM
(2-013) National survey assessing the public’s perceptions of amyloid-targeting drugs for Alzheimer’s Disease
Favorite
10:45 AM - 11:45 AM
(2-014) Agreement between Vancomycin Area Under the Curve (AUC) Estimates with Pre-Steady State versus Steady State Concentrations Using Bayesian Modeling
Favorite
10:45 AM - 11:45 AM
(2-015) Clinical Cure Rates of Gram Negative Bloodstream Infections Treated with Beta-Lactam Antibiotics in Obese Patients
Favorite
10:45 AM - 11:45 AM
(2-016) Antibiotic Prescribing Patterns in Patients with Penicillin Allergies: A Comparison Before and After Deactivation of the Cross-Reactivity Pop-Up Warning
Favorite
10:45 AM - 11:45 AM
(2-017) Three ERBB4-Dependent Human Melanoma Cell Lines Are Also Dependent on ERBB2
Favorite
10:45 AM - 11:45 AM
(2-018) Healthcare Providers’ Perceptions Regarding Ease of Using the Prescription Drug Monitoring Program (PDMP) Before and After an Interdisciplinary Workshop in Alabama
Favorite
10:45 AM - 11:45 AM
(2-019) Influential Factors Associated with Fentanyl Test Strip Provision by Alabama Community Pharmacists: a Cross-Sectional Survey
Favorite
10:45 AM - 11:45 AM
(2-020) Efficacy of an In-house Pharmacist-Led Single Level Vancomycin Area Under the Curve Therapeutic Drug Monitoring Service in a Pediatric Hospital Setting
Favorite
10:45 AM - 11:45 AM
(2-021) Expanding Pharmacogenomics in the Community Pharmacy Setting: Alabama Pharmacists’ Thoughts and Perceptions
Favorite
10:45 AM - 11:45 AM
(2-022) Exploring student identity formation through the use of technology: Let’s jam!
Favorite
10:45 AM - 11:45 AM
(2-023) Female First and Senior Authorship in Pharmacy Publishing
Favorite
10:45 AM - 11:45 AM
(2-024) Assessment of psychiatric disorders associated with elevated blood pressure and hypertension diagnosis
Favorite
10:45 AM - 11:45 AM
(2-025) Don’t Sleep on It: Exploring the Link Between Sleep Agents and Mood Disorders—A Prescription Pattern Analysis
Favorite
10:45 AM - 11:45 AM
(2-026) Health Markers of Non-communicable Diseases: a Cross-Cultural Comparison of the Maldives and Alabama
Favorite
10:45 AM - 11:45 AM
(2-027) Prevalence of Antibiotic Resistance in Initial Wound Culture Among Patients Admitted to the Burn Intensive Care Unit
Favorite
10:45 AM - 11:45 AM
(2-028) Improving Pneumococcal Vaccine Rates in Pediatric Liver Transplant Patients
Favorite
10:45 AM - 11:45 AM
(2-029) Assessing the Outcomes of the Implementation of Lipid Screenings During Pharmacist-Led Medicare Annual Wellness Visits (MAWVs) for Statin Treated Patients
Favorite
10:45 AM - 11:45 AM
(2-030) Functional Characterization of An Investigational Corrector Targeting the First Nucleotide-Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator
Favorite
10:45 AM - 11:45 AM
(2-031) Retrospective Analysis of Oral Care Agent Use in a Rehabilitation Center
Favorite
10:45 AM - 11:45 AM
(2-032) Evaluation of Pharmacy Personnel Regarding Preparedness During Electronic System Downtime
Favorite
10:45 AM - 11:45 AM
(2-033) Evaluating the usage and titration of glucagon-like peptide-1 receptor agonists in patients with uncontrolled type 2 diabetes mellitus
Favorite
10:45 AM - 11:45 AM
(2-034) Safety and Efficacy of Hydrocortisone Discontinuation Strategies in Septic Shock
Favorite
10:45 AM - 11:45 AM
(2-035) Assessing the Impact of Naloxone Administration Training in Transitional Living Facilities
Favorite
10:45 AM - 11:45 AM
(2-036) Evaluating trends in suicide deaths by drug poisoning in U.S. children and adolescents (ages 5-19) in 2002-2022 using Centers for Disease Control and Prevention data
Favorite
10:45 AM - 11:45 AM
(2-037) Evaluation of transferring patient immunization profiles between southeastern states
Favorite
10:45 AM - 11:45 AM
(2-038) Evaluation of Delay in Lumbar Puncture due to Venous Thromboembolism Prophylaxis in Neurology Population
Favorite
10:45 AM - 11:45 AM
(2-039) Review of Neuromodulation Devices for Prevention and Acute Treatment of Migraine and Headache Disorders
Favorite
10:45 AM - 11:45 AM
(2-040) The Use of Antidepressants, Stimulants, and Anxiety Medications in Samford McWhorter School of Pharmacy Students
Favorite
10:45 AM - 11:45 AM
(2-042) Error Reporting Perceptions and Behaviors by Arizona Pharmacists
Favorite
10:45 AM - 11:45 AM
(2-043) Social Predictors of Ability to Perform Daily Activities Among United States Adults with Heart Disease or Cardiometabolic Risk Factors
Favorite
10:45 AM - 11:45 AM
(2-044) Prevalence and Predictors of Nonmedical or Polydrug Stimulant Misuse Among Past-Year Users of Prescribed Stimulants
Favorite
10:45 AM - 11:45 AM
(2-045) Geographic and Social Predictors of Up-To-Date Colorectal Cancer Screening in U.S. Adults Aged 45 to 75 Years
Favorite
10:45 AM - 11:45 AM
(2-046) Association of Social Determinants of Health with Up-to-Date Cervical Cancer Screening Status
Favorite
10:45 AM - 11:45 AM
(2-047) Association of Racial Awareness and Perceived Discrimination with COVID-19 Vaccination in U.S. Hispanic Adults
Favorite
10:45 AM - 11:45 AM
(2-048) Predictors of Inadequate Emotional Support Among U.S. Adults Living with Cancer
Favorite
10:45 AM - 11:45 AM
(2-049) Early History of Illegal Psychoactive Substance Use and Later-Life Dysfunction in Cognition or Communication in U.S. Adults Aged 35 Years or Older
Favorite
10:45 AM - 11:45 AM
(2-050) National Organization for Rare Disorders’ State Resource Center: 600+ Free or Low-Cost Programs and Services for People Impacted by Rare Diseases
Favorite
10:45 AM - 11:45 AM
(2-051) Association of Perceived Risks of Health Behaviors with Problematic Substance Use: Raising Awareness of Health Education Opportunities
Favorite
10:45 AM - 11:45 AM
(2-052) Computational Screening for ALKBH7 Inhibitors for the Treatment of Brain Cancer
Favorite
10:45 AM - 11:45 AM
(2-053) Linking Chronic Diseases with Negative Social Determinants of Health: Barriers to Effective Medication Management
Favorite
10:45 AM - 11:45 AM
(2-054) Racial Intersectionality and Deaths of Despair: Implications for the Practice of Pharmacy
Favorite
10:45 AM - 11:45 AM
(2-055) Social Determinants of Health Predictors of Heavy Alcohol Use with Prescription Opioids, Tranquilizers, Sedatives, or Stimulants
Favorite
10:45 AM - 11:45 AM
(2-056) Pharmacy student perceptions of a virtual curriculum on providing care to individuals with intellectual and developmental disabilities
Favorite
10:45 AM - 11:45 AM
(2-057) Evaluation of Eravacycline- or Tigecycline-Containing Triple Therapy Versus a Clinical Acinetobacter baumannii Strain in Time Kill Analysis
Favorite
10:45 AM - 11:45 AM
(2-058) Association Between Healthcare Access Indicators and Social Determinants of Health (SDOH) and COVID-19 Vaccination Uptake Among US Black and Hispanic adults
Favorite
10:45 AM - 11:45 AM
(2-060) Misuse of Prescribed Medications for Approved Versus Non-Approved Indications: Predictors and Implications for Ambulatory Care
Favorite
10:45 AM - 11:45 AM
(2-061) Factors Influencing Self-Reported Health Status Among United States Adults with Arthritis
Favorite
10:45 AM - 11:45 AM
(2-062) Evaluating Diabetic Patient Adherence Amidst the Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Shortage
Favorite
10:45 AM - 11:45 AM
(2-063) Evaluating the impact of BioFire Blood Culture Identification 2 (BCID2) result reporting on time to targeted antimicrobial therapy
Favorite
10:45 AM - 11:45 AM
(2-064) Geographical Growth Trends Amongst Patients Living with Alpha-gal Syndrome
Favorite
10:45 AM - 11:45 AM
(2-065) Identifying Preventable and Non-preventable Prescription Callbacks for Clarification at an Academic Medical Center Emergency Department from 2015-2024
Favorite
10:45 AM - 11:45 AM
(2-066) Analysis of the Impact of Decentralizing Pharmacists on the Standard of Patient Care at Mountain Vista Medical Center
Favorite
10:45 AM - 11:45 AM
(2-067) Factors Influencing Posaconazole Concentrations in Hospitalized Patients Receiving Delayed Release Tablets
Favorite
10:45 AM - 11:45 AM
(2-068) Association between pain intensity and health service utilization (emergency room visits, inpatient discharges, office visits, outpatient visits) among adults with pain in the United States.
Favorite
10:45 AM - 11:45 AM
(2-069) Analysis of Responses from Artificial Intelligence Programs to Medication-Related Questions Derived from Critical Care Guidelines
Favorite
10:45 AM - 11:45 AM
(2-070) Evaluating the accuracy of pharmaceutical calculation solutions produced by artificial intelligence
Favorite
10:45 AM - 11:45 AM
(2-071) UA Pharmacy Interns Insights: Exploring Job Satisfaction and Factors Affecting Student Pharmacists
Favorite
10:45 AM - 11:45 AM
(2-072) Systematic Review of Psychedelics in Mental Health Disorders
Favorite
10:45 AM - 11:45 AM
(2-073) Exploring Professional, Patient, and Student Perceptions of Innovative Pharmacist Roles in Non-Traditional Settings
Favorite
10:45 AM - 11:45 AM
(2-074) Student-Led Pharmacy Technician Certification Review
Favorite
10:45 AM - 11:45 AM
(2-075) Prevalence of Renal Dysfunction and Potential Modifiable Risk Factors for Disease Progression in the Population of Northwest Nicaragua
Favorite
10:45 AM - 11:45 AM
(2-076) Assessing the Impact of a Urinalysis with Reflex to Urine Culture Order on Diagnostic Stewardship in a Pediatric Emergency Department
Favorite
10:45 AM - 11:45 AM
(2-077) Assessing the Utilization of Diagnostic Testing in Pediatric Urinary Tract Infections in a Pediatric General Clinic
Favorite
10:45 AM - 11:45 AM
(2-078) Impact of an Escape Room Simulation on Pharmacy Student Knowledge and Confidence in Pain Management and Opioid Stewardship
Favorite
10:45 AM - 11:45 AM
(2-079) Impacts of Student-Centered Learning in a Pharmaceutical Calculations Course
Favorite
10:45 AM - 11:45 AM
(2-080) Characterizing Empiric Antimicrobial Selection and Duration in Different Clinic Settings for the Treatment of Pediatric Urinary Tract Infections
Favorite
10:45 AM - 11:45 AM
(2-081) Does Weight Stigma Impact Empiric Antimicrobial Selection for Treatment of Pediatric Community Acquired Pneumonia (CAP) within the Emergency Department (ED)?
Favorite
10:45 AM - 11:45 AM
(2-082) Evaluation of Clopidogrel Initiation and Monitoring in the Pediatric Population
Favorite
10:45 AM - 11:45 AM
(2-083) Exploring the Effects of Mounjaro®, a Dual GLP and GLP-1 Receptor Agonist, on Lipoprotein (a) Levels in Patients with Type 2 Diabetes
Favorite
10:45 AM - 11:45 AM
(2-085) Spanish Diabetes Group Education Sessions in a Medically Underserved Community
Favorite
10:45 AM - 11:45 AM
(2-086) ASHP Council on Pharmacy Practice; a Student’s Perspective
Favorite
10:45 AM - 11:45 AM
(2-087) Comparison of Basal Insulins in Type 2 Diabetes Mellitus with Concomitant Severe Chronic Kidney Disease or End Stage Renal Disease
Favorite
10:45 AM - 11:45 AM
(2-088) An Assessment of Acute Kidney Injury Rates in Trauma Patients: A Retrospective Chart Review
Favorite
10:45 AM - 11:45 AM
(2-089) Evaluation of Peripheral Versus Central Line Initiation of Vasopressors at a Community Hospital
Favorite
10:45 AM - 11:45 AM
(2-090) Medicinal Chemistry-Driven Discovery of Small Molecules Active Against Parasitic Infections
Favorite
10:45 AM - 11:45 AM
(2-091) Population Pharmacokinetics of Cobicistat in Pregnant and Postpartum Women with HIV
Favorite
10:45 AM - 11:45 AM
(2-092) Combination Sodium-Glucose Cotransporter-2 Inhibitors with Glucagon-Like Peptide-1 Receptor Agonists in Veterans with Type 2 Diabetes on Major Cardiovascular Events and Heart Failure
Favorite
10:45 AM - 11:45 AM
(2-093) Inpatient Management of Sickle Cell Crisis in a Community Hosptial
Favorite
10:45 AM - 11:45 AM
(2-094) Countermeasures for Space Radiation: An Umbrella Review of Antioxidants
Favorite
10:45 AM - 11:45 AM
(2-095) Code ACS Simulation in Emergency Medicine: Enhancing Student Learning Through Faculty-Student Co-Creation
Favorite
10:45 AM - 11:45 AM
(2-096) Impact of Pharmacists’ Interventions on Patient’s Length of Stay: A Systematic Review
Favorite
10:45 AM - 11:45 AM
(2-098) Incidence of Hypersensitivity Reactions in Breast Cancer Patients After Discontinuing Dexamethasone with the Fourth Dose in Weekly Paclitaxel
Favorite
10:45 AM - 11:45 AM
(2-099) Evaluating Hyperkalemia in Transgender Adolescents Using Spironolactone: A Retrospective Chart Review Study
Favorite
10:45 AM - 11:45 AM
(2-100) Next-Gen HIV Treatment: The Financial Stability and Clinical Success of Long-Acting Antiretrovirals
Favorite
10:45 AM - 11:45 AM
(2-101) Mental health impacts of heat and climate events on residents of Bayview-Hunters Point: a qualitative interview study.
Favorite
10:45 AM - 11:45 AM
(2-102) Outcomes of a Pharmacist Managed Post-Hematopoietic Stem Cell Transplantation Immunization Clinic at a Comprehensive Cancer Center
Favorite
10:45 AM - 11:45 AM
(2-103) Perceptions of Barriers to Naloxone Dispensing in Orange County Pharmacies
Favorite
10:45 AM - 11:45 AM
(2-104) Accessibility of Over-the-Counter Emergency Contraception within different areas in Orange County
Favorite
10:45 AM - 11:45 AM
(2-105) Systematic Review of Safety and Efficacy of Glucagon-like Peptide-1 Receptor Agonists in Liver Transplant Recipients with Diabetes
Favorite
10:45 AM - 11:45 AM
(2-106) Population Pharmacokinetics of Ritonavir in Pregnancy and Postpartum Women with HIV
Favorite
10:45 AM - 11:45 AM
(2-107) Model-Predicted Pharmacokinetic Exposure Analysis of Amodiaquine in Pediatric Populations Across African Countries
Favorite
10:45 AM - 11:45 AM
(2-108) Medicare Drug Price Negotiation: The Complexities of Choosing Therapeutic Alternatives and Developing an Initial Offer
Favorite
10:45 AM - 11:45 AM
(2-110) Differential Anticoagulation Effects From Warfarin Therapy
Favorite
10:45 AM - 11:45 AM
(2-111) The Impact of Risperidone-Induced Weight Gain on Different Patient Phenotypes
Favorite
10:45 AM - 11:45 AM
(2-112) Effect of tenofovir on tissue reservoirs in postmortem samples from people with human immunodeficiency virus (HIV) on antiretroviral therapy (ART)
Favorite
10:45 AM - 11:45 AM
(2-113) Predictors of Ceftriaxone and Carbapenem Use Among Hospitalized Patients in Quetzaltenango, Guatemala: An ARCH Study
Favorite
10:45 AM - 11:45 AM
(2-114) Monitoring of Liver Fibrosis by Noninvasive Measures in Chronic Hepatitis B Patients Receiving Long-term Tenofovir—based Treatment
Favorite
10:45 AM - 11:45 AM
(2-115) Additional Evidence for an Explanation of Why Bioavailability for Alternate Administration Routes of Certain Drugs May Be Greater than for Intravenous Administration
Favorite
10:45 AM - 11:45 AM
(2-116) Clinical effect of preemptive pharmacogenomic testing of CYP3A5 on transplant patients treated with TAC at a research hospital
Favorite
10:45 AM - 11:45 AM
(2-117) Clinical Outcomes of TPMT and NUDT15 Pharmacogenetic Testing in Azathioprine Therapy at UCSF Health
Favorite
10:45 AM - 11:45 AM
(2-118) Drug-Drug Interaction Between Dihydroartemisinin-Piperaquine and Sulfadoxine-Pyrimethamine in Pregnant Women During Malaria Chemoprevention
Favorite
10:45 AM - 11:45 AM
(2-119) Investigating Care Coordination Models Across Inpatient Pharmacy Specialties
Favorite
10:45 AM - 11:45 AM
(2-120) Model-Informed Tenofovir Dose Adjustments in Pediatric Patients: A Pharmacokinetic Approach to Achieve Optimal Drug Exposure
Favorite
10:45 AM - 11:45 AM
(2-121) Pharmacokinetic-Pharmacodynamic Driven Investigations of the Mechanism of Sirolimus to Decrease Human Immunodeficiency Virus Reservoir
Favorite
10:45 AM - 11:45 AM
(2-122) The Impact of As Needed Anticholinergic Medication Use in Older Adults on Anticholinergic Burden During Hospitalization
Favorite
10:45 AM - 11:45 AM
(2-123) Emtricitabine Exposure on Tissue Reservoirs in Postmortem Samples from People with Human Immunodeficiency Virus on Antiretroviral Agent
Favorite
10:45 AM - 11:45 AM
(2-124) Impact of Cirrhosis on Severity and Outcome of Staphylococcus aureus Bacteremia
Favorite
10:45 AM - 11:45 AM
(2-126) Trough-based vs AUC:MIC based Monitoring of Vancomycin: Impact on Nephrotoxicity and Efficacy at PIH Health Good Samaritan Hospital
Favorite
10:45 AM - 11:45 AM
(2-127) Real-World Implications of CABENUVA in a HIV-1 Treatment Setting: An Observational Study
Favorite
10:45 AM - 11:45 AM
(2-128) Hypertonic Saline for Traumatic Brain Injury or Stroke: A Retrospective Chart Review
Favorite
10:45 AM - 11:45 AM
(2-129) Effects of Poppi Soda on Human Gut Microbiota
Favorite
10:45 AM - 11:45 AM
(2-130) The Impact of Glucuronolactone on Cardiovascular Parameters in Energy Drinks
Favorite
10:45 AM - 11:45 AM
(2-131) Evaluating the Effects of Enhanced External Counterpulsation on Symptoms of Long COVID: a Systematic Review
Favorite
10:45 AM - 11:45 AM
(2-132) Impact of Granola Formulated with Unrefined Sugar Compared to Other Leading Granola Brands on Blood Glucose
Favorite
10:45 AM - 11:45 AM
(2-133) Impact of Nelumbo nucifera in Improving Sleep Quality: A Randomized, Double-blind, Placebo-controlled Trial
Favorite
10:45 AM - 11:45 AM
(2-134) Exploring the Potential Application of Cinnamon for UV Irradiation-Induced Skin Damage
Favorite
10:45 AM - 11:45 AM
(2-135) Statin Prescribing Practices for Veterans with HIV at Single-Center Veterans Affairs Health Care System
Favorite
10:45 AM - 11:45 AM
(2-136) Exploring the Acute Hemodynamic Effects of Normatec 3 Therapy
Favorite
10:45 AM - 11:45 AM
(2-137) Antiretroviral Medication Errors Among Veterans with HIV Hospitalized at a Veteran Affairs Health Care System
Favorite
10:45 AM - 11:45 AM
(2-138) The Use of Cinnamon Extract in Cancer Therapy through Modulating the PD-L1/PD-1 Pathway
Favorite
10:45 AM - 11:45 AM
(2-139) Exploring Homeopathy's Role in Palliative Care for Cancer Patients
Favorite
10:45 AM - 11:45 AM
(2-140) An Evaluation of Institutional Compliance to an Acute Hematogenous Osteomyelitis Algorithm at a Pediatric Hospital
Favorite
10:45 AM - 11:45 AM
(2-141) Assessing the Correlation Between Surrogate Endpoints and Clinical Benefit in Oncology Accelerated Approvals: A Comparative Analysis
Favorite
10:45 AM - 11:45 AM
(2-143) Tolerability Of Sodium Glucose Cotransporter 2 Inhibitors in Left Ventricular Assist Device Patients
Favorite
10:45 AM - 11:45 AM
(2-144) Antibiotic Stewardship in Surgical Prophylaxis: A Retrospective Medication Use Evaluation
Favorite
10:45 AM - 11:45 AM
(2-145) False-Positive Amphetamine Urine Toxicology Results in Patients Taking Labetalol: Case Report
Favorite
10:45 AM - 11:45 AM
(2-146) Flipping Out? Perceived Stress Levels and Student Perceptions of Flipped Classroom Models at USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Favorite
10:45 AM - 11:45 AM
(2-147) Prevalence of Potential Delayed Hepatotoxicity in Cystic Fibrosis Patients on Elexacaftor/Tezacaftor/Ivacaftor
Favorite
10:45 AM - 11:45 AM
(2-148) Real-World Patient Profiles, Treatment Patterns, and Outcomes in a Diverse Population with Multiple Myeloma
Favorite
10:45 AM - 11:45 AM
(2-149) Efficacy of Pre-Class Asynchronous Recordings on Student Performance in Flipped Classroom Settings
Favorite
10:45 AM - 11:45 AM
(2-150) Omadacycline Use in Mycobacterioides abcessus Peritonitis; a Case Report
Favorite
10:45 AM - 11:45 AM
(2-151) Evaluation of Extended Release Versus Immediate Release Dosage Form Errors at a Community Hospital
Favorite
10:45 AM - 11:45 AM
(2-152) Accuracy and Reproducibility of ChatGPT Responses to Real-World Drug Information Questions
Favorite
10:45 AM - 11:45 AM
(2-153) Advances in Cardiovascular Pharmacogenetics: From Risk Prediction to Therapeutic Optimization
Favorite
10:45 AM - 11:45 AM
(2-154) Implementing Pharmacy-Patient Care Processes: Comparison Pre- and Post-Implementation of Virtual-Based Simulations
Favorite
10:45 AM - 11:45 AM
(2-155) Approval Rates for Prior Authorizations of Commonly Prescribed Medications in a Patient-Centered Medical Home
Favorite
10:45 AM - 11:45 AM
(2-156) The Impact of Physician’s Experience and Pharmacist’s Communication Method on Accepting Recommendations for Potentially Inappropriate Medications in a Patient-Centered Medical Home
Favorite
10:45 AM - 11:45 AM
(2-157) Time Spent on Prior Authorizations for Commonly Prescribed Medications in a Patient-Centered Medical Home
Favorite
10:45 AM - 11:45 AM
(2-158) Rates of Potentially Inappropriate Medication Prescribing for Resident and Attending Physicians in a Patient-Centered Medical Home.
Favorite
10:45 AM - 11:45 AM
(2-159) Evaluation of the Top 20 Ingredients in Sexual and Muscle Enhancement Dietary Supplements: Promoting Counseling for Safe Utilization
Favorite
10:45 AM - 11:45 AM
(2-160) Determining Human Papillomavirus Vaccine Knowledge, Education, and Practices among Pharmacy Students and Faculty: A Qualitative Initiative
Favorite
10:45 AM - 11:45 AM
(2-161) Evaluation of the relationship between the classification system of outpatient drugs and their utilization across the healthcare landscape.
Favorite
10:45 AM - 11:45 AM
(2-162) Flushing Out the Cause: Anticholinergic Toxicity from Atropine Eye Drops
Favorite
10:45 AM - 11:45 AM
(2-163) Evaluating Opportunities and Use of Aprepitant in a Community Health System
Favorite
10:45 AM - 11:45 AM
(2-164) Retrospective review of albumin usage at a level-one trauma center and safety-net hospital
Favorite
10:45 AM - 11:45 AM
(2-165) Ertapenem Induced Neutropenia, a Rare Adverse Effect and Literature Review
Favorite
10:45 AM - 11:45 AM
(2-166) Impact of Obesogen Exposure on Trisomy 21
Favorite
10:45 AM - 11:45 AM
(2-167) Pharmacokinetics of Ceftriaxone in Adult Patients Weighing 80kg or More
Favorite
10:45 AM - 11:45 AM
(2-168) Analysis of a Systematic Program to Transition Patients on Warfarin to Direct Oral Anticoagulants
Favorite
10:45 AM - 11:45 AM
(2-169) Dehydrating Dilemma: A Case of Neonatal Diabetes Insipidus
Favorite
10:45 AM - 11:45 AM
(2-170) Assessment of Laboratory Monitoring Practices for Outpatient Prescription Medications in Children with Medical Complexity
Favorite
10:45 AM - 11:45 AM
(2-171) Adherence to Criteria for Use for Intravenous Acetaminophen following Implementation of a System-Wide Formulary
Favorite
10:45 AM - 11:45 AM
(2-172) Turmeric - Warfarin Interaction Resulting in Supratherapeutic INR, Bleeding, and Hospitalization
Favorite
10:45 AM - 11:45 AM
(2-173) Pharmacy Intern Derived Flu Immunization Workflow to Increase Efficiency
Favorite
10:45 AM - 11:45 AM
(2-174) Medication Use Evaluation of RiaSTAP in a Teaching Hospital
Favorite
10:45 AM - 11:45 AM
(2-175) Impact on Patient Care through a Pharmacy Intern Led Psychiatric Medication Education Group
Favorite
10:45 AM - 11:45 AM
(2-176) Use of psychotropic medication for pediatric patients with diabetes mellitus type 1 and disordered eating: A case report and literature review.
Favorite
10:45 AM - 11:45 AM
(2-177) Evaluation of Hyponatremia at Elevation: A Retrospective Review
Favorite
10:45 AM - 11:45 AM
(2-178) Expanding the Donor Pool: A Case Series Utilizing Hepatitis B NAT Positive Heart Transplant Allografts in Hepatitis B NAT Negative Recipients
Favorite
10:45 AM - 11:45 AM
(2-179) Pharmacodynamic Effects of Intra-Articular and Epidural Triamcinolone on Blood Glucose in Patients with Type-2 Diabetes
Favorite
10:45 AM - 11:45 AM
(2-180) Classic Psychedelic Treatment of Anxiety Disorders
Favorite
10:45 AM - 11:45 AM
(2-182) Business Proposal: Integration of clinical pharmacy services into the outpatient hematology-oncology setting
Favorite
10:45 AM - 11:45 AM
(2-183) Evaluation of Adherence to Long-Acting Injectable Naltrexone Post-Discharge in Patients with Substance Use Disorder in a Veterans Affairs (VA) Healthcare System
Favorite
10:45 AM - 11:45 AM
(2-184) Antibiotic Stewardship in the Emergency Department: Preliminary Impact of Rapid Diagnostics and Provider Education
Favorite
10:45 AM - 11:45 AM
(2-185) Impact of of allergy recommendation integrated antibiotic order-sets (AIAO) on the utilization of penicillin and cephalosporins in patients with anaphylactic allergy labels
Favorite
10:45 AM - 11:45 AM
(2-186) Antimicrobial Stewardship in Pediatric Emergency Departments and Discharge: A Systematic Review
Favorite
10:45 AM - 11:45 AM
(2-187) Kratom Products Exceed Safe Lead Levels in Children and Women of Child-Bearing Potential
Favorite
10:45 AM - 11:45 AM
(2-188) The Effects of Ketamine Treatment on Anxiety Disorders
Favorite
10:45 AM - 11:45 AM
(2-189) Risk of Charley Horse Pain with Insulin Titration in Patients with Type 2 Diabetes Mellitus
Favorite
10:45 AM - 11:45 AM
(2-190) The Impact of Fourth Year Pharmacy Student-Driven Medication Reconciliation in a Cardiac Surgery Step-Down Unit
Favorite
10:45 AM - 11:45 AM
(2-191) Evaluation of Intravenous Hypertonic Saline Administration Strategies among Patients with Acute Symptomatic Hyponatremia
Favorite
10:45 AM - 11:45 AM
(2-192) Evaluation of Calcium Repletion Order Set in Continuous Renal Replacement Therapy
Favorite
10:45 AM - 11:45 AM
(2-193) Evaluation of Nurse-Driven Heparin Protocol Compliance in Hospitalized Patients
Favorite
10:45 AM - 11:45 AM
(2-195) Evaluation of Pharmacist Impact on Time to Anticoagulation Reversal in the Emergency Department
Favorite
10:45 AM - 11:45 AM
(2-196) Factors Influencing Adherence to Follow-Up Dalbavancin Appointments in Intravenous Drug Users
Favorite
10:45 AM - 11:45 AM
(2-197) Unpacking Trends in ICU Cefepime and Piperacillin-Tazobactam Use
Favorite
10:45 AM - 11:45 AM
(2-198) A Systematic Review of Interventions to Reduce Pediatric Antibiotic Prescriptions: a focus on the research from resource-limited countries and multiple-site studies conducted in high-income countries
Favorite
10:45 AM - 11:45 AM
(2-199) Interventions to Reduce Pediatric Antibiotic Prescriptions in Pediatric Outpatient Clinics: A Systematic Review
Favorite
10:45 AM - 11:45 AM
(2-200) Impact of weight loss surgery on valproic acid levels
Favorite
10:45 AM - 11:45 AM
(2-201) Lithium-induced Psychogenic Polydipsia in a Patient with Schizoaffective Disorder
Favorite
10:45 AM - 11:45 AM
(2-202) Evaluating Drug Manufacturers’ Responses to Animal-Free Inquiries: A Nonsystematic Review of Accuracy, Response Time, and Impact on Patient Experience
Favorite
10:45 AM - 11:45 AM
(2-203) Nip by Nip: Assessing the Link Between Miniature Alcohol Sales and DUI Crashes
Favorite
10:45 AM - 11:45 AM
(2-204) Validation of a High Throughput Method for Bio-Sample Screening in Idiopathic Hypersomnia
Favorite
10:45 AM - 11:45 AM
(2-205) A Pharmacist’s Role in Navigating Pharmacokinetic Variables in Brain Death Determination
Favorite
10:45 AM - 11:45 AM
(2-206) The Therapeutic Potential of Salubrinal on the Pathophysiology of ME/CFS and Long- COVID
Favorite
10:45 AM - 11:45 AM
(2-207) Medication Usage Evaluation(MUE) Coagulation factor Xa and 4Factor PCC
Favorite
10:45 AM - 11:45 AM
(2-208) New FDA Approval: A Literature Review Supporting the Use of Pivya for Uncomplicated Urinary Tract Infections
Favorite
10:45 AM - 11:45 AM
(2-209) Balancing Patient Privacy and Healthcare Innovation: Addressing Trust and Ethical Concerns in Patient-Reported Outcome Data
Favorite
10:45 AM - 11:45 AM
(2-210) Comparison of New Alzheimer's Disease Treatments: Donanemab (Kisunla) and Lecanemab (Leqembi) Versus Established Therapies
Favorite
10:45 AM - 11:45 AM
(2-211) Impact on Health Outcomes and Medication Adherence of Patients Who Access Their Healthcare Portal in an Uninsured Population
Favorite
10:45 AM - 11:45 AM
(2-212) Pharmacists as a Resource for Reducing Health Disparities: A Literature Review
Favorite
10:45 AM - 11:45 AM
(2-213) Assessing the Influence of Socioeconomic Factors on Medication Adherence Among Older Adults Living with HIV in Low-income Communities
Favorite
10:45 AM - 11:45 AM
(2-214) An Assessment of Pharmacy Burnout Post COVID-19
Favorite
10:45 AM - 11:45 AM
(2-215) Impacting Effects of Post-Discontinuation of Injectable Semaglutide and Oral Semglutide on Weight and HbA1c in Type 2 Diabetes: POSITIVE-T2D
Favorite
10:45 AM - 11:45 AM
(2-216) Analyzing the African American pharmacist workforce in Central Florida and the effects of racial concordance on patient outcomes and health disparities
Favorite
10:45 AM - 11:45 AM
(2-217) Impact of Work on the Mental Health Status of Student Pharmacists and Faculty in Pharmacy
Favorite
10:45 AM - 11:45 AM
(2-219) The Role of Artificial Intelligence in Pharmacy: A Comparison of Clinical Interpretations
Favorite
10:45 AM - 11:45 AM
(2-220) Evaluation of the Timeliness of an Electrolyte Protocol at a Community Hospital System
Favorite
10:45 AM - 11:45 AM
(2-221) Hemoglobin-Based Oxygen Carrier-201 (HBOC-201) Use in Treating Life-Threatening Anemia Post-CABG in a Blood Refusal Patient Case
Favorite
10:45 AM - 11:45 AM
(2-222) Evaluating Liver Transplantation and Chemotherapy Ablation in Colorectal Liver Metastasis
Favorite
10:45 AM - 11:45 AM
(2-223) Examining Long-Acting Injectable Antipsychotic Prescribing and Transition of Care Practices in an Acute Behavioral Health Care Setting
Favorite
10:45 AM - 11:45 AM
(2-224) Impact of an Intensive Care Unit Pharmacist-to-Patient Ratio in a Community Teaching Hospital
Favorite
10:45 AM - 11:45 AM
(2-225) Review of the Investigational Use of Single, Dual, and Pan-Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Favorite
10:45 AM - 11:45 AM
(2-226) HIV Co-infection with Mycobacterium Szulgiae: Clinical Insights and Management Challenges
Favorite
10:45 AM - 11:45 AM
(2-227) Sotatercept: Breathing New Life into Pulmonary Arterial Hypertension Treatment
Favorite
10:45 AM - 11:45 AM
(2-228) Enhanced Anti-inflammatory Effects of Liraglutide when Combined with Roflumilast in Cardiac Cells
Favorite
10:45 AM - 11:45 AM
(2-229) Investigating Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors for Safe and Effective Use in Heart Failure with Reduced Ejection Fraction: A Systematic Review of the Literature
Favorite
10:45 AM - 11:45 AM
(2-230) Navigating the Dual Challenges of Pain Management in Patients with Pain Syndromes and Cardiovascular Disorders: A Scoping Review
Favorite
10:45 AM - 11:45 AM
(2-231) Assessing Hospital Pharmacists' Knowledge and Perception of Metabolic Dysfunction-Associated Steatohepatitis (MASH): Interventions, Patient Education, and Clinical Impact.
Favorite
10:45 AM - 11:45 AM
(2-232) Transformative Gene Therapies for Sickle Cell Disease: Exagamglogene Autotemcel and Lovotibeglogene Autotemcel
Favorite
10:45 AM - 11:45 AM
(2-233) Analysis of Analgesics Use for Management of Chronic Pain Conditions Among Adults Over Time
Favorite
10:45 AM - 11:45 AM
(2-234) Exploring the Emerging Therapeutic Applications of Glucagon-Like Peptide-1 Receptor Agonists Beyond Glycemic Control: A Comprehensive Review
Favorite
10:45 AM - 11:45 AM
(2-235) Rezdiffra (resmetirom), a novel therapeutic agent in the treatment of non-alcoholic steatohepatitis (NASH)
Favorite
10:45 AM - 11:45 AM
(2-236) Medication use Evaluation of post-intubation analgosedation at Memorial Hospital West Emergency Department
Favorite
10:45 AM - 11:45 AM
(2-237) Impact of integrated outpatient parenteral antimicrobial therapy (OPAT) pharmacy services on healthcare utilization
Favorite
10:45 AM - 11:45 AM
(2-238) Risk Factors for Hospital Readmission in Patients Discharged with Outpatient Parental Antimicrobial Therapy: An Observational Cohort Study
Favorite
10:45 AM - 11:45 AM
(2-239) Evaluating the Impact of Increased Utilization of Automated Pyxis Dispensing Systems on Hospital Pharmacy Workflow
Favorite
10:45 AM - 11:45 AM
(2-240) Empowering Pharmacy Services: The Future of On-Demand Technician Support
Favorite
10:45 AM - 11:45 AM
(2-241) Leveraging YouTube to Enhance Cervical Cancer Prevention: Insights from YouTube Content and Engagement Metrics
Favorite
10:45 AM - 11:45 AM
(2-242) Rx for Success: Teaching in the iGen Era
Favorite
10:45 AM - 11:45 AM
(2-243) Comparing Anticholinergic Load and As-Needed Medication Administrations in an Impatient State Psychiatric Hospital: A Retrospective Analysis
Favorite
10:45 AM - 11:45 AM
(2-244) Tripping or Triggered? Differential Diagnosis and Management of Hallucination Persistent Perception Disorder: A Clinical Case Report
Favorite
10:45 AM - 11:45 AM
(2-245) Use of Drugs Known To Cause Drug-Induced Liver Injury (DILI) Among Adults NHANES 2003-2020
Favorite
10:45 AM - 11:45 AM
(2-246) Mental Health Wellness Programs in the Top 20 U.S. Hospitals: A Best Practices Analysis
Favorite
10:45 AM - 11:45 AM
(2-247) BumpILY: A Pharmacist-Driven Prenatal Care Concept and Prototype
Favorite
10:45 AM - 11:45 AM
(2-248) Exploring the Role of Pharmacists in Infertility Management: A Scoping Review
Favorite
10:45 AM - 11:45 AM
(2-249) Clinical Presentation and Management of Hereditary Angioedema with Airway Compromise: A Case Report
Favorite
10:45 AM - 11:45 AM
(2-250) The Pressure Is On for Resistant Hypertension: The Use of Tryvio (aprocitentan) in Resistant Hypertension
Favorite
10:45 AM - 11:45 AM
(2-251) The Use of Quizartinib in Acute Myeloid Leukemia: A Review
Favorite
10:45 AM - 11:45 AM
(2-252) Trends in the History of Marijuana Use Among Adults in the United States, NHANES 2005-2018
Favorite
10:45 AM - 11:45 AM
(2-253) Impact of Pharmacist-Led Care on Clinical Health Outcomes for Underserved Populations in Federally Qualified Health Centers: A Systematic Review
Favorite
10:45 AM - 11:45 AM
(2-254) Management of Systemic Lupus Erythematosus Exacerbation in a Pregnant Patient: Role of the Critical Care Pharmacist
Favorite
10:45 AM - 11:45 AM
(2-255) Ceftobiprole: A Review of Evidence for the Novel Cephalosporin with Activity against MRSA
Favorite
10:45 AM - 11:45 AM
(2-256) Polypharmacy and Falls in the Elderly: A Systematic Review and Meta Analysis
Favorite
10:45 AM - 11:45 AM
(2-257) Linezolid Utilization Patterns Across a Level 1 Trauma Center
Favorite
10:45 AM - 11:45 AM
(2-258) Fruquintinib for the treatment of adult patients with previously treated metastatic colorectal cancer- a scoping review
Favorite
10:45 AM - 11:45 AM
(2-259) Psychopharmacology for the management of chemotherapy-induced cognitive impairment: a scoping review
Favorite
10:45 AM - 11:45 AM
(2-260) Shots of Protection: Pharmacy Students on the Frontlines of Flu, COVID-19, and Shingles Immunizations
Favorite
10:45 AM - 11:45 AM
(2-261) Complex Condition Interactions: A Case Study of Schizophrenia in a Patient with Traumatic Brain Injury
Favorite
10:45 AM - 11:45 AM
(2-262) Dead Woman Walking: A Closer Look at Cotard’s Syndrome as a Manifestation of Schizophrenia
Favorite
10:45 AM - 11:45 AM
(2-263) Examining the Potential of 3,4-Methylenedioxymethamphetamine (MDMA) for Treating Post - Traumatic Stress Disorder (PTSD) and Depression: A Scoping Review
Favorite
10:45 AM - 11:45 AM
(2-264) Real World Evidence: Demographic of South Florida Subethnic African American Women with Triple Negative Breast Cancer
Favorite
10:45 AM - 11:45 AM
(2-265) Under the Radar: Uncovering Arachnoid Cysts in Schizophrenia, Highlighting Differential Diagnosis
Favorite
10:45 AM - 11:45 AM
(2-266) Predictors of Human Papillomavirus (HPV) Vaccination Uptake among College Students in the United States
Favorite
10:45 AM - 11:45 AM
(2-267) TeleSlim
Favorite
10:45 AM - 11:45 AM
(2-268) Evaluating Cannabinoid Quality and Stability in Commercial Hemp Products: Implications for Abuse Prevention and Public Health
Favorite
10:45 AM - 11:45 AM
(2-269) Donanemab: Untangling the Web of Alzheimer's Care
Favorite
10:45 AM - 11:45 AM
(2-270) Evaluating the Treatment Outcomes and Recurrence of Clostridioides difficile Infections Following Fecal Microbiota Transplantation
Favorite
10:45 AM - 11:45 AM
(2-272) Evaluating Glucagon Utilization and Adherence to Protocol at JFK North: A Medication Use Evaluation
Favorite
10:45 AM - 11:45 AM
(2-273) Determining if Glucagon Administration Appropriateness Will Improve Before and After Nursing Education – A Quality Improvement Project
Favorite
10:45 AM - 11:45 AM
(2-274) Evaluation of Factor Eight Inhibitor Bypassing Activity (FEIBA) Administration for the Reversal of Direct Oral Anticoagulants (DOACs) in Patients at a Community Hospital
Favorite
10:45 AM - 11:45 AM
(2-275) Evaluation of Fidaxomicin Prescribing Patterns for the Treatment of Clostridioides Difficile in a Community-Based Health System
Favorite
10:45 AM - 11:45 AM
(2-276) Assessment of Inhaler Waste and Related Costs in Patients at a Community Hospital
Favorite
10:45 AM - 11:45 AM
(2-277) Off-Label Use of Teplizumab in a Patient with Early Stage 3 Type 1 Diabetes Mellitus
Favorite
10:45 AM - 11:45 AM
(2-278) Evaluation of a Nurse-Driven Clinical Institute Withdrawal Assessment for Alcohol Revised (CIWA-Ar) Protocol Within a Hospital System
Favorite
10:45 AM - 11:45 AM
(2-279) Assessing the Correlation Between Baseline Diabetes Knowledge and Point of Care Blood Glucose Results in Hispanic Individuals: A Pharmacists- and Student Pharmacists-Led Screening Study
Favorite
10:45 AM - 11:45 AM
(2-280) A Retrospective Chart Review of the Use of Guideline Directed Mediated Therapy in Patients with Heart Failure Referred for Pharmacy Consultation at a Community Hospital
Favorite
10:45 AM - 11:45 AM
(2-281) Exploring Pipeline Therapies: Are Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) and Glucose-dependent Insulinotropic Polypeptides (GIP) the Next Frontier for Metabolic Liver Disease?
Favorite
10:45 AM - 11:45 AM
(2-282) Clinical Presentation of Multiple Sclerosis (MS) Symptoms Leading to Multiple Sclerosis (MS) Diagnosis in Minority Populations in The United States
Favorite
10:45 AM - 11:45 AM
(2-283) Title: Exploring the Distribution of Community-Based Pharmacy Residency Programs in Medically Underserved Areas and Primary Care Health Professional Shortage Areas
Favorite
10:45 AM - 11:45 AM
(2-284) Evaluation of Antibiotic Selection for Open Fractures in the Emergency Department
Favorite
10:45 AM - 11:45 AM
(2-285) SGLT2 Inhibitors in Geriatric Care: A Risk-Benefit Decision-Making Approach
Favorite
10:45 AM - 11:45 AM
(2-286) Evaluating Safety and Efficacy of Intraosseous Vancomycin in Preventing Periprosthetic Joint Infections Following Revision Total Knee Arthroplasty: A 30 and 90-Day Outcome Analysis
Favorite
10:45 AM - 11:45 AM
(2-287) Pilot Study: Assessing Time to Antifungal Treatment using a Rapid Diagnostic Tool versus Conventional Blood Cultures for Detecting Candida in Positive Blood Cultures.
Favorite
10:45 AM - 11:45 AM
(2-288) Artificial Intelligence for Pharmacy Information and Education
Favorite
10:45 AM - 11:45 AM
(2-289) Midodrine safety in heart failure patients
Favorite
10:45 AM - 11:45 AM
(2-290) Translating Real-World Evidence into Practice: Improving Adherence, Persistence, and Tolerability to Oral Oncolytics in Patients With HR+/HER2- Breast Cancer
Favorite
10:45 AM - 11:45 AM
(2-291) Evaluation of antimicrobial management of neonatal patients with suspected or confirmed necrotizing enterocolitis and development of a standardized order set
Favorite
10:45 AM - 11:45 AM
(2-292) Ceftriaxone induced acute hepatic injury: a case report
Favorite
10:45 AM - 11:45 AM
(2-293) Evaluation of the Efficacy and Safety of 2-Infusion N-acetylcysteine in Pediatric Acetaminophen Toxicity
Favorite
10:45 AM - 11:45 AM
(2-294) Drug-Drug Interactions During Statin Associated Immune-Mediated Necrotizing Myopathy Treatment with Pharmacogenomic Implications
Favorite
10:45 AM - 11:45 AM
(2-295) Enhancing Compliance to CDC Opioid Guidelines in an Anesthesiology Pain Clinic
Favorite
10:45 AM - 11:45 AM
(2-296) Improvement of Allodynia following Discontinuation of Semaglutide in a Patient with Type 2 Diabetes Mellitus and History of COVID-19
Favorite
10:45 AM - 11:45 AM
(2-297) Evaluating the Efficacy of Enteral P2Y12 Inhibitors in Preventing Acute Stent Thrombosis Post-Percutaneous Coronary Intervention with Drug-Eluting Stents in ST-Elevation Myocardial Infarction with Cardiogenic Shock
Favorite
10:45 AM - 11:45 AM
(2-298) Evaluation of Written Patient Communication Journey on Registration Trends Within a Virtual Pharmacogenetics Consultation Service
Favorite
10:45 AM - 11:45 AM
(2-299) Evaluating Patient Awareness, Knowledge and Experience in a Pharmacogenetic Consult Clinic: Assessing Hispanic vs Non-Hispanic Population
Favorite
10:45 AM - 11:45 AM
(2-300) Assessing the Allocation of Community-Based Residency Programs in Socially Vulnerable Locations
Favorite
10:45 AM - 11:45 AM
(2-301) Addressing Glycemic Control Challenges After Removing Sulfonylureas from the Inpatient Formulary
Favorite
10:45 AM - 11:45 AM
(2-302) Cost Savings with Sacubitril-Valsartan: A Split Decision on Waste Reduction in a Hospital Setting
Favorite
10:45 AM - 11:45 AM
(2-303) Evaluation of Appropriate Oral Step-Down Therapy in Patients with Urinary Tract Infections Caused by Extended-Spectrum Beta-Lactamase Producing Escherichia Coli (E. coli)
Favorite
10:45 AM - 11:45 AM
(2-304) Evaluation of Clindamycin Utilization for Surgical Antimicrobial Prophylaxis in the Penicillin or Cephalosporin Allergic Patient
Favorite
10:45 AM - 11:45 AM
(2-305) Evaluation of Intravenous Levothyroxine Use at an Academic Medical Center
Favorite
10:45 AM - 11:45 AM
(2-306) Evaluation of Prescribing Patterns for the Treatment of Clostridioides difficile with Oral Vancomycin in a Community-Based Health System
Favorite
10:45 AM - 11:45 AM
(2-307) Intravenous immunoglobulin utilization patterns and cost analysis in a teaching hospital: one year later
Favorite
10:45 AM - 11:45 AM
(2-308) Cannabinoid Hyperemesis Syndrome: The Impact of Droperidol Use in the Emergency Department on Admission Rates
Favorite
10:45 AM - 11:45 AM
(2-309) Evaluation of Andexanet alfa for Direct Oral Anticoagulant (DOAC) Reversal
Favorite
10:45 AM - 11:45 AM
(2-310) HIV Pre-Exposure Prophylaxis Care Continuum in Outpatient Settings: A Systematic Review and Meta-Analysis
Favorite
10:45 AM - 11:45 AM
(2-311) Usability Evaluation of Pharmacogenomic Clinical Decision Support at a Large Academic Medical Center
Favorite
10:45 AM - 11:45 AM
(2-312) Analysis of Total Parental Nutrition (TPN) in post-transplant patients
Favorite
10:45 AM - 11:45 AM
(2-313) DNA Mutational Profiling in Colorectal Cancer: A Focus on the RNF43 Mutation
Favorite
10:45 AM - 11:45 AM
(2-314) Increasing adherence to scheduled patient encounter times in an outpatient oncology clinic
Favorite
10:45 AM - 11:45 AM
(2-315) Prolonged Discrepancy in Methotrexate Level Assays After Glucarpidase Administration
Favorite
10:45 AM - 11:45 AM
(2-316) Racial Disparity in Cardiovascular Adverse Events of Aromatase Inhibitor Use in Breast Cancer
Favorite
10:45 AM - 11:45 AM
(2-317) Pharmacogenomic Phenotyping Via Salivary pH Modifications
Favorite
10:45 AM - 11:45 AM
(2-318) Rebound Menopausal Vasomotor Symptoms with Concomitant Use of Caffeine and VEOZAH® (fezolinetant)
Favorite
10:45 AM - 11:45 AM
(2-319) Florida Gators Want You! To Implement a Pharmacy Skills Lab Teaching Assistant Program
Favorite
10:45 AM - 11:45 AM
(2-320) Is it a Win-win? Student Perceptions on the Benefits of a Skills Lab Teaching Assistant Program
Favorite
10:45 AM - 11:45 AM
(2-321) Impact of a Student Pharmacist Teaching Assistant Program on Career Interest and Abilities within Pharmacy Academia
Favorite
10:45 AM - 11:45 AM
(2-322) An Analysis of Physician-Reported Adverse Events in Florida’s Medical Marijuana Use Registry
Favorite
10:45 AM - 11:45 AM
(2-323) Assessing Time Savings and Provider Satisfaction in a Pharmacy-Led Transitions of Care Service
Favorite
10:45 AM - 11:45 AM
(2-324) Establishing the True Effectiveness of Pharmacist-Led Comprehensive Medication Reviews on Healthcare Outcomes
Favorite
10:45 AM - 11:45 AM
(2-325) Impact of Pharmacy-Led Medication History Pilot Program on Medication Discrepancies
Favorite
10:45 AM - 11:45 AM
(2-326) Retrospective study of testosterone use in gender-affirming therapy and adherence to testosterone prescribing guidelines
Favorite
10:45 AM - 11:45 AM
(2-327) Extended-Release Tacrolimus Dosing in Obese Kidney Transplant Recipients
Favorite
10:45 AM - 11:45 AM
(2-328) Implementation of Wellness Days for Pharmacy Students during Advanced Pharmacy Practice Experiences
Favorite
10:45 AM - 11:45 AM
(2-329) Evaluation of Safe Use of Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors at an Academic Medical Center
Favorite
10:45 AM - 11:45 AM
(2-330) Hypophosphatemia Associated with Ferric Carboxymaltose: a Real-World Experience of a Hidden Complication
Favorite
10:45 AM - 11:45 AM
(2-331) Incidence of Venous Thromboembolism Post-Spontaneous Intracerebral Hemorrhage
Favorite
10:45 AM - 11:45 AM
(2-332) Evaluation of Nitroprusside Infusions in Cardiothoracic Surgery Patients in a Community Hospital
Favorite
10:45 AM - 11:45 AM
(2-333) Evaluating Changes in Prescription Patterns of Sodium Glucose Co-transporters inhibitors (SGLT2i) and 30-Day Readmissions in Heart Failure (HF) Patients Following Guideline Updates and Internal Interventions
Favorite
10:45 AM - 11:45 AM
(2-334) Central Catheters and Thromboembolism in Pediatric Patients with Cardiac Disease
Favorite
10:45 AM - 11:45 AM
(2-335) Quality Improvement: Evaluation of Medication Safety Practice Utilization in a Doctor of Pharmacy Curriculum
Favorite
10:45 AM - 11:45 AM
(2-336) Assessing the Relationship Between Job-Related Factors and Pharmacists’ Perception of Satisfaction with Work Conditions
Favorite
10:45 AM - 11:45 AM
(2-337) Incidence of Hypocalcemia in Trauma Patients After Receiving Massive Transfusion at a Level 2 Trauma Center
Favorite
10:45 AM - 11:45 AM
(2-338) Evaluation of Amiodarone Prescribing Trends
Favorite
10:45 AM - 11:45 AM
(2-339) Increasing Utilization of Statins in Type 2 Diabetes Patients
Favorite
10:45 AM - 11:45 AM
(2-340) Ambulatory Guideline-Directed Medical Therapy in Heart Failure with Preserved Ejection Fraction: Real-World Data from a Large Academic Center Cohort
Favorite
10:45 AM - 11:45 AM
(2-341) Evaluation of Alternative Drugs and Therapies Used by Patients in a Student-Run Free Clinic
Favorite
10:45 AM - 11:45 AM
(2-342) Reviewing Effects of Pre-Intensive Care Unit Antidepressants on Post-Intensive Care Syndrome (REPAIR-PICS)
Favorite
10:45 AM - 11:45 AM
(2-343) Creation of a Tool to Assess Psychological Safety in Pharmacy Education Environments
Favorite
10:45 AM - 11:45 AM
(2-344) Implementation of Remote Physiologic Monitoring in an Accountable Care Organization
Favorite
10:45 AM - 11:45 AM
(2-345) Evaluate Time to Therapeutic Levels in Adult Patients Receiving Intravenous Unfractionated Heparin for Treatment of Venous Thromboembolisms in a Community Healthcare System
Favorite
10:45 AM - 11:45 AM
(2-346) Medication Use Evaluation: Use of Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors
Favorite
10:45 AM - 11:45 AM
(2-347) Characterizing Pulmonary Edema After Naloxone Administration Using Real World Data
Favorite
10:45 AM - 11:45 AM
(2-348) Evaluation of Rabbit Antithymocyte Globulin Weight-Based Dosing in Pediatric Kidney Transplant Patients
Favorite
10:45 AM - 11:45 AM
(2-349) Impact of Pharmacist-Driven Pre-Transplant Education on Pediatric Renal Transplant Patient Outcomes
Favorite
10:45 AM - 11:45 AM
(2-350) An Evaluation of the Quality of Datapoints Used to Predict Student Progression-Related Events Within in a PharmD Program
Favorite
10:45 AM - 11:45 AM
(2-351) Analysis of influenza vaccination status in influenza-positive patients during the 2023-2024 influenza season
Favorite
10:45 AM - 11:45 AM
(2-352) Racial Disparities in Young Adult Kidney Transplant Recipients: A Retrospective Cohort Study
Favorite
10:45 AM - 11:45 AM
(2-353) Evaluating Patient Perceptions of Skin Disease during Pharmacist Interventions in Atopic Dermatitis
Favorite
10:45 AM - 11:45 AM
(2-354) Impact of Pharmacy Intern Interventions on Managing Hyperlipidemia in Patients with an LDL greater than 190 mg/dL
Favorite
10:45 AM - 11:45 AM
(2-355) Evaluation of International Normalized Ratio Values in Patients Receiving Warfarin Therapy Using Vizient’s International Normalized Ratio-Based Metric Performance
Favorite
10:45 AM - 11:45 AM
(2-356) Octreotide to Prevent or Reduce Gastrointestinal Bleeding in Patients with Left Ventricular Assist Devices
Favorite
10:45 AM - 11:45 AM
(2-357) Utilization of Project BOOST (Building Optimal Outcomes through Strategic Training) in Evaluating Long-Term Impact of Immunization Training for Nigerian Pharmacists
Favorite
10:45 AM - 11:45 AM
(2-358) Complementary and Alternative Medicine: Bringing the Gap Between Evidence-Based Practice and Patient Preference
Favorite
10:45 AM - 11:45 AM
(2-359) Evaluation of the rate of euglycemic ketoacidosis as a significant adverse event associated with the usage of continuous renal replacement therapy
Favorite
10:45 AM - 11:45 AM
(2-360) Description of Services and Patient Experiences During a Multidisciplinary Medical/Surgical Mission Trip to Benin City, Nigeria
Favorite
10:45 AM - 11:45 AM
(2-361) To Crush, or Not to Crush, That Is the Question: Cinacalcet for a Patient with Hypercalcemia and Amyotrophic Lateral Sclerosis
Favorite
10:45 AM - 11:45 AM
(2-362) Compliance and Efficacy of High-Dose Droperidol Administration in Emergency Departments
Favorite
10:45 AM - 11:45 AM
(2-363) Evaluation of safety of direct oral anticoagulant use in older adults at a safety net academic medical center
Favorite
10:45 AM - 11:45 AM
(2-364) A multidisciplinary perspective on the feasibility of HIV pre-exposure prophylaxis being available over-the-counter
Favorite
10:45 AM - 11:45 AM
(2-365) Micronutrient Depletion in Extracorporeal Membrane Oxygenation: A Patient Case
Favorite
10:45 AM - 11:45 AM
(2-366) Assessing Dexamethasone Antiemetic Use in Patients Receiving Highly Emetogenic Chemotherapy with Immune Checkpoint Inhibitors
Favorite
10:45 AM - 11:45 AM
(2-367) Medication Use Evaluation of Glucarpidase Administration at an Academic Healthcare System
Favorite
10:45 AM - 11:45 AM
(2-368) Patient perspectives on Anal Cancer: A qualitative assessment of detection, diagnosis, and treatment considerations
Favorite
10:45 AM - 11:45 AM
(2-369) Rituximab and Paclitaxel Use in Anthracycline-Resistant Acquired Immunodeficiency Syndrome Related Kaposi Sarcoma Complicated by Castleman’s Disease - a Case Report
Favorite
10:45 AM - 11:45 AM
(2-370) Toeing the line with Angiotensin II: A Medication Use Evaluation
Favorite
10:45 AM - 11:45 AM
(2-371) Therapy Options in Refractory Anti-NMDA Receptor Autoimmune Encephalitis
Favorite
10:45 AM - 11:45 AM
(2-372) A comparison of states’ smoking and quit attempt rates by pharmacists’ authority to prescribe cessation medications
Favorite
10:45 AM - 11:45 AM
(2-373) Evaluating the Use of Apixaban for Atrial Fibrillation in End Stage Renal Disease Patients
Favorite
10:45 AM - 11:45 AM
(2-374) Highlighting the Impact of Tacrolimus Interactions on Transplant Patients
Favorite
10:45 AM - 11:45 AM
(2-375) Exploring Brugada Syndrome and Its Role in Sudden Cardiac Death: Pharmacological Management Strategies
Favorite
10:45 AM - 11:45 AM
(2-376) From Vacation to Critical Illness: A Case Report of Recurrent Sepsis in a Patient with Systemic Lupus Erythematosus: Diagnostic and Therapeutic Challenges
Favorite
10:45 AM - 11:45 AM
(2-377) Electronic health care record for objective structured clinical examination stations at Philadelphia College of Osteopathic Medicine School of Pharmacy Georgia Campus during 2022-2023 academic year
Favorite
10:45 AM - 11:45 AM
(2-378) Analyzing Alumni Trends for a New Pharmacy School: A Decade of Impact on Pharmacy Practice and Leadership
Favorite
10:45 AM - 11:45 AM
(2-379) Stellate Ganglion Block (SGB) Treatment of Post-Traumatic Stress Disorder: A Peer Review Analysis
Favorite
10:45 AM - 11:45 AM
(2-380) Cannabis Withdrawal Syndrome in Individuals With Chronic or Dependent Use of Cannabinoids: A Case Report
Favorite
10:45 AM - 11:45 AM
(2-381) Discovering the Therapeutic Potential of Mounjaro® (tirzepatide): A Case Report
Favorite
10:45 AM - 11:45 AM
(2-382) Enhancing Antibiotic Stewardship Through Interprofessional Collaboration
Favorite
10:45 AM - 11:45 AM
(2-383) Type 1 Diabetes Management Success with Tirzepatide, Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonist Use: A Case Report
Favorite
10:45 AM - 11:45 AM
(2-384) Monotherapy versus Combination Therapy Targeting Pseudomonas aeruginosa in Hospital-Acquired and Ventilator-Associated Pneumonia
Favorite
10:45 AM - 11:45 AM
(2-385) Recently Reported Adverse Effects of Miscellaneous Antibiotics
Favorite
10:45 AM - 11:45 AM
(2-386) Use of Virtual Influencers (VI) and Artificial Intelligence (AI) technology to optimize patient education
Favorite
10:45 AM - 11:45 AM
(2-387) Optimizing Statin Education: Impact of Counseling Formats on Patient Understanding and Retention Phase 2 – Development of Visual and Auditory Educational Material
Favorite
10:45 AM - 11:45 AM
(2-388) Semaglutide vs Liraglutide and The Difference in The Cardiovascular Benefits of These Medications
Favorite
10:45 AM - 11:45 AM
(2-389) Assessing Instructional Strategies: Metaphor-Based Videos vs. Traditional Handouts in Pharmacy Course
Favorite
10:45 AM - 11:45 AM
(2-390) Current Strategies and Future Dimensions in the Development of Kirsten Rat Sarcoma Virus Inhibitors for Targeted Anticancer Therapy
Favorite
10:45 AM - 11:45 AM
(2-391) Impact of Labetalol vs. Methyldopa on Infant Outcomes in Severe Pre-eclampsia: A Retrospective Review
Favorite
10:45 AM - 11:45 AM
(2-392) Investigating Student Professionalism during Advanced Pharmacy Practice Experience, Preceptors versus Students
Favorite
10:45 AM - 11:45 AM
(2-393) Assessing Inappropriate Medication Prescribing in Patients with Chronic Kidney Disease Discharged from the Emergency Department
Favorite
10:45 AM - 11:45 AM
(2-394) Optimizing Statin Education: Impact of Counseling Formats on Patient Understanding and Retention: Phase 3- Evaluation of Educational Materials
Favorite
10:45 AM - 11:45 AM
(2-395) Implementation of Cardiology Provider Report Cards to Improve Heart Failure Guideline-Directed Medical Therapy Prescribing
Favorite
10:45 AM - 11:45 AM
(2-396) Optimizing Statin Education: Impact of Counseling Formats on Patient Understanding and Retention Phase 1 – Development of Educational Materials and Assessment Tools
Favorite
10:45 AM - 11:45 AM
(2-397) A Retrospective Review of the Distribution of Use between Calcium Channel Blocker Compared to Beta Blocker therapy in Hypertensive Crisis
Favorite
10:45 AM - 11:45 AM
(2-398) Interprofessional Student Perspectives and Knowledge of Oncology
Favorite
10:45 AM - 11:45 AM
(2-399) Evaluation of Rates of Fentanyl Overdose with Co-Morbid Skin and Soft Tissue Infection
Favorite
10:45 AM - 11:45 AM
(2-400) Analyzing the Relationship between SSRIs/SNRIs and Hypertension
Favorite
10:45 AM - 11:45 AM
(2-401) Desk-Bound Recess: The Impact of Exercise on Pharmacy Students’ Blood Pressure
Favorite
10:45 AM - 11:45 AM
(2-402) Effects of Low-Intensity Physical Activity Breaks on Engagement: From a Pharmacy Student and Professor Perspective
Favorite
10:45 AM - 11:45 AM
(2-403) Impact of Physical Activity Breaks on Student Pharmacist Mood and Burnout
Favorite
10:45 AM - 11:45 AM
(2-404) Addressing Healthcare Gaps for Women: The Pharmacist's Role in Improving ECHO Outcomes Aligned with Healthy People 2030 Objectives
Favorite
10:45 AM - 11:45 AM
(2-405) Community Pharmacist Diabetes Care Services
Favorite
10:45 AM - 11:45 AM
(2-406) Characterization of Emergency Department Visits and Hospital Admissions for Pediatric Patients with Type 1 Diabetes Mellitus
Favorite
10:45 AM - 11:45 AM
(2-407) Mapping Georgia's Retail Pharmacies: An analysis of access to care among Georgia's rural and urban communities.
Favorite
10:45 AM - 11:45 AM
(2-408) Evaluation of Parenteral Anticoagulant Utilization for Venous Thromboembolism Prophylaxis in High-Risk Obstetric Patients
Favorite
10:45 AM - 11:45 AM
(2-409) Medication Process Evaluation of Bowel Regimen Initiation and Timing in Patients on Patient-Controlled Analgesia (PCA)
Favorite
10:45 AM - 11:45 AM
(2-410) Evaluation of Seizure Recurrence in Patients Administered an IV Loading Dose of Levetiracetam for Breakthrough Seizures in an Emergency Department
Favorite
10:45 AM - 11:45 AM
(2-411) Gabapentin reduces narcotic exposure in infants after stage II palliation
Favorite
10:45 AM - 11:45 AM
(2-412) Comparison of Adjusted Vancomycin Regimens Calculated by Intermittent Infusion (IIF) Versus Area Under the Curve (AUC) Methods.
Favorite
10:45 AM - 11:45 AM
(2-413) Comparison of Initial Vancomycin Regimens Calculated by Intermittent Infusion (IIF) Versus Area Under the Curve (AUC) Methods
Favorite
10:45 AM - 11:45 AM
(2-414) Evaluating Pharmacists' Confidence and Perceptions in Ambulatory Care Pharmacy Services: A Comparison Between Low and High Prescription Volumes
Favorite
10:45 AM - 11:45 AM
(2-415) From Barriers to Breakthroughs: The Role of Pharmacy in Reducing Emergency Department Visits through Medication Assistance Programs
Favorite
10:45 AM - 11:45 AM
(2-416) Analysis of the Utilization of Intravenous (IV) Acetaminophen in the Perioperative Setting After Cardiothoracic Surgery
Favorite
10:45 AM - 11:45 AM
(2-417) Analysis of Pharmacokinetics and Treatment Failure with Intravenous Push Cefepime in Critically Ill Patients with Sepsis
Favorite
10:45 AM - 11:45 AM
(2-418) Comparison of Patient Outcomes in Different Intensive Care Units at an Academic Medical Center: an OPTIM Analysis
Favorite
10:45 AM - 11:45 AM
(2-419) Effect of Consistent Clinical Pharmacy Personnel Coverage During First 48 Hours of ICU Stay on Patient Outcomes for Patients with Weekday Admission: an OPTIM Analysis
Favorite
10:45 AM - 11:45 AM
(2-420) Effect of Pharmacist Rounding Time on Patient Outcomes: A Subgroup Analysis of the OPTIM Study
Favorite
10:45 AM - 11:45 AM
(2-421) Impact of Pharmacists Rounding on an Intensive Care Unit Patient on Their First Day of Admission on Patient Outcomes: An OPTIM Subgroup Analysis
Favorite
10:45 AM - 11:45 AM
(2-422) Impact of Weekday vs Weekend ICU Admissions on Patient Outcomes: An Optimizing Pharmacist Team-Integration for ICU Patient Management (OPTIM) Subgroup Analysis
Favorite
10:45 AM - 11:45 AM
(2-423) Resuscitation Fluid Dosing Using Ideal Body Weight in Septic Shock: Impact on Vasopressor Requirements
Favorite
10:45 AM - 11:45 AM
(2-424) Comparison of Medication Turnaround Times for Intravenous Push versus Piggyback Administration of Levetiracetam Doses >1500 mg at an Urban Safety Net Hospital
Favorite
10:45 AM - 11:45 AM
(2-425) Evaluation of Carbapenem Prescribing Practices for Non-bloodstream Extended-Spectrum-Beta-Lactamase (ESBL) Infections at an Academic Medical Center
Favorite
10:45 AM - 11:45 AM
(2-426) Evaluation of Remdesivir Use at an Academic Medical Center
Favorite
10:45 AM - 11:45 AM
(2-427) Extended Spectrum Beta-Lactamase (ESBL) Escalation Alerts from Rapid Blood Culture Identification via Polymerase Chain Reaction Testing
Favorite
10:45 AM - 11:45 AM
(2-428) Leveraging Electronic Medical Record Education for Antimicrobial Stewardship in Enterococcus faecalis Bacteremia
Favorite
10:45 AM - 11:45 AM
(2-429) Medication Use Evaluation of Levofloxacin for Stenotrophomonas maltophilia Infections
Favorite
10:45 AM - 11:45 AM
(2-430) Real-world Evaluation of Adherence to Fluconazole Duration during Consolidation and Maintenance Phases in Patients with HIV-associated Cryptococcosis: A Claims-Based Study
Favorite
10:45 AM - 11:45 AM
(2-431) Evaluating the Usability of a Mobile Micro-Learning Application on Over-the-Counter Contraception and Opioid Safety Products for Use by Community Pharmacists
Favorite
10:45 AM - 11:45 AM
(2-432) Comparing Pharmacy Student Confidence in Accreditation Council for Pharmacy Education Standards Before and After Completing Advanced Pharmacy Practice Experiences
Favorite
10:45 AM - 11:45 AM
(2-433) Five Year Outcomes of a Multi-campus, Multi-semester Applied Critical Care Research Elective
Favorite
10:45 AM - 11:45 AM
(2-434) Assessing areas of improvement for five Georgia counties with the lowest annual household income and other key social determinants of health
Favorite
10:45 AM - 11:45 AM
(2-435) Health Outcomes and Social Determinants of Health in Rural Counties
Favorite
10:45 AM - 11:45 AM
(2-436) Evaluating the Effects of a Pilot Mobile Micro-Learning Application on Community Pharmacist Comfort and Confidence regarding Over-the-Counter Contraception and Opioid Use Disorder Products
Favorite
12:00 PM - 1:00 PM
(3-001) Utilization of Diabetic Medications Following the Hurricanes in Puerto Rico Compared to Hawaii 2016 to 2022
Favorite
12:00 PM - 1:00 PM
(3-002) Pharmacotherapy Interventions in Ventilator Care Bundles for Preventing Ventilator-Associated Pneumonia in Adults: A Literature Review
Favorite
12:00 PM - 1:00 PM
(3-003) Development of a Comprehensive Interaction Database Between Hawaiian Medicinal Herbs and Anticancer Drugs
Favorite
12:00 PM - 1:00 PM
(3-004) Asian Participation in Clinical Trials Leading to First FDA Approval for Top 10 Forecasted Drug Products in 2024
Favorite
12:00 PM - 1:00 PM
(3-005) Evaluation of Patient Eligibility for Continuous Glucose Monitor Utilization at the East Hawaii Health Primary Care Clinic
Favorite
12:00 PM - 1:00 PM
(3-006) Examining Adverse Effects Reported to the FDA on Glucagon-Like Peptide-1 Receptor Agonists and Glucagon-Like Peptide-1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonists
Favorite
12:00 PM - 1:00 PM
(3-007) Retrospective Evaluation of Piperacillin-Tazobactam Utilization in General Surgery Patients within a Medical Center
Favorite
12:00 PM - 1:00 PM
(3-008) Comparing Systolic and Diastolic Blood Pressure Values from Eight Different Cities on Hawai’i Island
Favorite
12:00 PM - 1:00 PM
(3-009) Assessing Pharmacist Impact on Lipid-Lowering Medication Prescribing in Patients with Diabetes in a Rural Setting
Favorite
12:00 PM - 1:00 PM
(3-010) An Analysis of US FDA Approved New Drug Therapies in 2024
Favorite
12:00 PM - 1:00 PM
(3-011) Evaluation of Renal-Protective Medication Use in Patients with Type 2 Diabetes and Chronic Kidney Disease in a Primary Care Clinic
Favorite
12:00 PM - 1:00 PM
(3-012) Evaluation of Droperidol Use for Acute Agitation in the Emergency Department
Favorite
12:00 PM - 1:00 PM
(3-013) Impact of pharmacist-led diabetes prevention programs on weight loss in a rural Hawaii community
Favorite
12:00 PM - 1:00 PM
(3-014) Examining the US FDA Approved Glucagon-Like-Peptide-1 Receptor Agonists from 2005-2024
Favorite
12:00 PM - 1:00 PM
(3-015) Evaluation of 2021 Standardized Antimicrobial Administration Ratios for Broad-Spectrum and Gram-Positive Antimicrobials with Nationwide Rates of Healthcare Associated MRSA and Multidrug Resistant Pseudomonas Aeruginosa
Favorite
12:00 PM - 1:00 PM
(3-016) Comparison of Substance Abuse Rates of Drug Groups (Fentanyl, Cocaine, Cannabis, Heroin, Opiates, Amphetamines) within the United States Army Prior to, During, and Post-COVID-19 Pandemic
Favorite
12:00 PM - 1:00 PM
(3-017) Comparison of Medicare Semaglutide and GLP-1 Receptor Agonists Prescribing Claims and Kidney Disease Deaths by State in 2022
Favorite
12:00 PM - 1:00 PM
(3-018) Addressing Counterfeit Risks and Shortages in the United States Drug Supply Chain: The Case of Semaglutide
Favorite
12:00 PM - 1:00 PM
(3-019) Comparison of Illicit Drugs of Abuse Usage Rates Among the Army Reserve and the Active Army in 2024
Favorite
12:00 PM - 1:00 PM
(3-020) Warfarin management in a rural physician-run clinic: Efficacy of In-Clinic Testing Compared to Home Monitoring
Favorite
12:00 PM - 1:00 PM
(3-021) Implementation and evaluation of cascade reporting on antimicrobial stewardship and promoting the use of narrow-spectrum antibiotics
Favorite
12:00 PM - 1:00 PM
(3-022) Prevalence and Dosing of Direct Oral Anticoagulants in the Management of Left Ventricular Thrombus
Favorite
12:00 PM - 1:00 PM
(3-023) Community Pharmacists in Medication-Assisted Therapy for Opioid Use Disorder: Facilitating Positive Outcomes Through Prescribing, Patient Management, and Primary Care Referrals
Favorite
12:00 PM - 1:00 PM
(3-024) Study Plan for a Case-Series of Medication Claims from Community Pharmacies in Idaho
Favorite
12:00 PM - 1:00 PM
(3-025) In Vitro Analysis of Embelin in Combination with Tyrosine Kinase Inhibitors for Treating Breast Cancer
Favorite
12:00 PM - 1:00 PM
(3-026) Let's Take a Trip! The Use of Psychedelic Compounds to Treat Mental Illness
Favorite
12:00 PM - 1:00 PM
(3-027) Overcoming Compliance Barriers: Enhancing Medication Adherence in Transplant Patients through an Integrated Health-System Mail Order Pharmacy Approach.
Favorite
12:00 PM - 1:00 PM
(3-028) Prevalence of Chinese Americans Eligible for Diabetes Screening: The Impact of Race-Specific BMI Thresholds
Favorite
12:00 PM - 1:00 PM
(3-029) Tolerance of Direct Cefazolin Use in Penicillin Allergic Patients with Moderate-to High-Risk for a Drug Allergy Reaction
Favorite
12:00 PM - 1:00 PM
(3-030) Assessing the Validity and Scientific Accuracy of Social Media “TikTok” Videos Surrounding Oral Contraception
Favorite
12:00 PM - 1:00 PM
(3-031) Mantle Cell Lymphoma - Dose Reduced Bendamustine in Severe Hepatic Impairment
Favorite
12:00 PM - 1:00 PM
(3-033) Evaluating the Influences on Pharmacy Students’ Professional Identity: A Longitudinal Study
Favorite
12:00 PM - 1:00 PM
(3-034) C-Reactive Protein as a Biomarker and Potential Therapeutic Option in High-Grade Serous Ovarian Cancer
Favorite
12:00 PM - 1:00 PM
(3-036) Prostate Cancer Prevalence in the United States
Favorite
12:00 PM - 1:00 PM
(3-037) Opioid antagonist Utilization Patterns in United States Emergency Department Visit: A Retrospective Study
Favorite
12:00 PM - 1:00 PM
(3-038) The Use of Artificial Intelligence in a Thematic Analysis of Performance Evaluation in Advanced Pharmacy Practice Experiences
Favorite
12:00 PM - 1:00 PM
(3-039) Illinois Council of Health-System Student Chapter Activities at Rosalind Franklin University
Favorite
12:00 PM - 1:00 PM
(3-040) What All Community Pharmacists Should Know About Veterinary Pharmacy and the Impact of an Educational Intervention
Favorite
12:00 PM - 1:00 PM
(3-041) Osteomyelitis in Pediatrics: Comparing Methicillin Resistant Staphylococcus aureus and Methicillin Sensitive Staphylococcus aureus Rates and Empiric Treatment at a Tertiary Care Center
Favorite
12:00 PM - 1:00 PM
(3-042) Prepping for the Future: An Evaluation of Healthcare Provider Prescribing Practices of HIV PrEP and PEP Medication Regimens
Favorite
12:00 PM - 1:00 PM
(3-043) Evaluating Antibiotic Use for Code Sepsis in the Emergency Department - A Retrospective Chart Review
Favorite
12:00 PM - 1:00 PM
(3-044) Evaluating the Implementation of 2022 ACC/AHA Guidelines for HFrEF: Prescribing of First-Line Therapies in Clinical Practice
Favorite
12:00 PM - 1:00 PM
(3-045) Assessing the Role of Vital Signs in Symptom-triggered Alcohol Withdrawal Scoring: A Retrospective Evaluation of the Alcohol Withdrawal Assessment Scale
Favorite
12:00 PM - 1:00 PM
(3-046) Evaluation of Intravenous Iron Replacement Therapy in a Community Teaching Hospital
Favorite
12:00 PM - 1:00 PM
(3-047) Impact of a Rapid Multiplex Polymerase Chain Reaction Blood Culture Identification Panel and a Pharmacist-driven Protocol on Antibiotic Management
Favorite
12:00 PM - 1:00 PM
(3-048) Role of Dapagliflozin in Attenuating Renal Tubule Damage: Immunohistochemical Analysis of a Diabetic Rat Model
Favorite
12:00 PM - 1:00 PM
(3-049) Analysis of Amoxicillin-Clavulanate Prescribing in Pediatric Primary Care
Favorite
12:00 PM - 1:00 PM
(3-050) Assessing the Efficacy and Safety of Undiluted Levetiracetam for Rapid Intravenous Push in Pediatric Emergency and Inpatient Settings
Favorite
12:00 PM - 1:00 PM
(3-051) Indomethacin Risk and Reward after 7 Days of Age in Neonates
Favorite
12:00 PM - 1:00 PM
(3-052) On-time Administration of Scheduled Albuterol in the Emergency Department
Favorite
12:00 PM - 1:00 PM
(3-053) The Impact of Interprofessional Collaboration on Pharmacy Students’ Learning in Maternal Health Emergencies
Favorite
12:00 PM - 1:00 PM
(3-054) Exploring the Relationship Between Sense of Belonging and Burnout Experience Among Pharmacy Students: A Quantitative-Comparative Study
Favorite
12:00 PM - 1:00 PM
(3-055) Impact of Pharmacist-Led Insulin Pump Service in Primary Care
Favorite
12:00 PM - 1:00 PM
(3-056) Aspirin Use for Secondary Cardiovascular Disease Prevention in Jamaica: Adherence and Barriers
Favorite
12:00 PM - 1:00 PM
(3-057) Evaluating Twice Daily versus Thrice Daily Low Dose Unfractionated Heparin for Venous Thromboembolism Prophylaxis in Elderly Hospitalized Patients
Favorite
12:00 PM - 1:00 PM
(3-058) Deprescribing Education in US Schools of Pharmacy
Favorite
12:00 PM - 1:00 PM
(3-059) Appropriate Discharge Antibiotic Selection, Dosing, and Duration for Urinary Tract Infections in the Emergency Department and Implications for Pharmacist Intervention
Favorite
12:00 PM - 1:00 PM
(3-060) Evaluating the Accessibility of Automated External Defibrillators in a Community Setting
Favorite
12:00 PM - 1:00 PM
(3-061) 7 Versus 14 Days of Antibiotic Therapy for Uncomplicated E. coli and K. pneumoniae Bacteremia: A Retrospective Study
Favorite
12:00 PM - 1:00 PM
(3-062) Impact of an Infectious Disease Consultation on Duration of Antibiotic Therapy in Uncomplicated Gram-Negative Bacteremia
Favorite
12:00 PM - 1:00 PM
(3-063) Reassessment of Documented Penicillin Allergies: Implications on Antibiotic Selection and Reaction Outcomes in Hospitalized Adults
Favorite
12:00 PM - 1:00 PM
(3-064) Optimizing Buprenorphine Initiation for Opioid Use Disorder in the Inpatient Setting: A Retrospective Chart Review
Favorite
12:00 PM - 1:00 PM
(3-065) Impact of COVID-19 on School Aged Children and Adolescent Mental Health
Favorite
12:00 PM - 1:00 PM
(3-066) Assessing the Attitudes, Perceptions, and Practices of Pharmacists Towards Deprescribing
Favorite
12:00 PM - 1:00 PM
(3-067) Assessing Organ Donation Registration Knowledge and Association with Blood Donor Status
Favorite
12:00 PM - 1:00 PM
(3-068) Evaluation of Pharmacists' and Student Pharmacists' Perspectives on the Development of a Women's Health Pharmacotherapy Course
Favorite
12:00 PM - 1:00 PM
(3-069) Treatment of urinary tract infections in infants less than 2 months of age
Favorite
12:00 PM - 1:00 PM
(3-070) Awareness and Perceptions of Fentanyl Criminalization Policies: A Survey Report
Favorite
12:00 PM - 1:00 PM
(3-071) Effectiveness of the University of Illinois Chicago Herbert M. and Carol H. Retzky College of Pharmacy’s Revised Teaching Methods on Visiting International Students
Favorite
12:00 PM - 1:00 PM
(3-072) Average Length of Stay in the Emergency Department When Prescribed an Intravenous or Oral Cephalosporin for Uncomplicated Urinary Tract Infections
Favorite
12:00 PM - 1:00 PM
(3-073) Improving Access to Long-Acting Antipsychotic Injectables within a Federally Qualified Health Center
Favorite
12:00 PM - 1:00 PM
(3-075) Retrospective Analysis of the Medications Taught in Pathophysiology, Drug Action, and Therapeutics Courses at the University of Illinois, Retzky College of Pharmacy
Favorite
12:00 PM - 1:00 PM
(3-076) Taking the Plunge Together: A Student-led Faculty Learning Seminar Series on Artificial Intelligence
Favorite
12:00 PM - 1:00 PM
(3-077) Improving Pediatric Venous Thromboembolism Risk Assessment: A Quality Improvement Initiative
Favorite
12:00 PM - 1:00 PM
(3-078) Cardiogenic Shock in the setting of Epstein-Barr Virus-Associated Myocarditis
Favorite
12:00 PM - 1:00 PM
(3-079) Prosthetic Peril: A Case Study of Penile Prosthesis Infection
Favorite
12:00 PM - 1:00 PM
(3-080) Characterizing Electronic Medical Record (EMR) Secure Chat Data in a Health-System Specialty Pharmacy
Favorite
12:00 PM - 1:00 PM
(3-081) The Effects of Implementing a Call Center on Workflow and Break in Tasks in an Ambulatory Care Pharmacy
Favorite
12:00 PM - 1:00 PM
(3-082) Acute Pancreatitis and Euglycemic Non-diabetic Ketoacidosis Caused by an Intentional Semaglutide Overdose
Favorite
12:00 PM - 1:00 PM
(3-083) Development of a Database for Measuring and Recording the Complexity of Studies Employing Investigational Drug Services
Favorite
12:00 PM - 1:00 PM
(3-084) Management of Complex Medication Regimens and the Universal Medication Schedule: An Interprofessional Skills Lab
Favorite
12:00 PM - 1:00 PM
(3-085) Adoption of Adalimumab Biosimilars Within Outpatient Pharmacies in a Health System
Favorite
12:00 PM - 1:00 PM
(3-086) Analysis of Pharmacist-Led Lab Reviews for Patients Treated with Capecitabine in a Health System Specialty Pharmacy
Favorite
12:00 PM - 1:00 PM
(3-087) Evaluating the Effects of Home Medication Delivery on Medication Adherence in Pediatric Patients with Sickle Cell Disease
Favorite
12:00 PM - 1:00 PM
(3-088) Hepatitis A and B Vaccine Administration Practices in the Illinois Department of Corrections Facilities
Favorite
12:00 PM - 1:00 PM
(3-089) Evaluating Biologic Discontinuation Reasons in Rheumatoid Arthritis and Psoriatic Arthritis: A Retrospective Analysis
Favorite
12:00 PM - 1:00 PM
(3-090) A Retrospective Study Comparing Pharmacist and Nurse Collaboration to Standard of Care Obesity and Overweight Treatment and Outcomes in Primary Care
Favorite
12:00 PM - 1:00 PM
(3-091) Effect of Vitalograph Aerosol Inhalation Monitor Implementation on a Multidisciplinary Chronic Obstructive Pulmonary Disease (COPD) Clinic
Favorite
12:00 PM - 1:00 PM
(3-092) Dual Antiplatelet Therapy Compared to Therapeutic Anticoagulation Status-Post Left Atrial Appendage Occlusion
Favorite
12:00 PM - 1:00 PM
(3-093) Pharmacogenomic guided optimization of P2Y12 inhibitor therapy
Favorite
12:00 PM - 1:00 PM
(3-094) Utilization of Effective Diuresis in Patients Admitted for Acute Decompensated Heart Failure
Favorite
12:00 PM - 1:00 PM
(3-095) Readmission Rates Following Co-Administration of Tetracycline or Fluoroquinolone Antibiotics with Divalent and Trivalent Cations in Hospitalized Patients for Treatment of Bacterial Infection
Favorite
12:00 PM - 1:00 PM
(3-096) Appropriate Adjustments of Inpatient Insulin Regimens after Recurrent Hyperglycemic Events
Favorite
12:00 PM - 1:00 PM
(3-097) Retrospective Analysis of Parenteral Nutrition Provided in a Level III Neonatal Intensive Care Unit (NICU)
Favorite
12:00 PM - 1:00 PM
(3-098) Evaluation of antiretroviral medications across a multi-hospital community health system
Favorite
12:00 PM - 1:00 PM
(3-099) Oral Antimicrobial Optimization for the Treatment of Uncomplicated Gram-Negative Bloodstream Infections
Favorite
12:00 PM - 1:00 PM
(3-100) Utilization of Pneumococcal Urinary Antigen Testing to Streamline Antibiotics in Patients with Suspected Community Acquired Pneumonia
Favorite
12:00 PM - 1:00 PM
(3-101) Buprenorphine for Pain Management Clinical Education Research Project
Favorite
12:00 PM - 1:00 PM
(3-102) Evaluating Practice Readiness After a Curriculum Change Integrating Important 200 Medications into Pharmacotherapeutics Courses.
Favorite
12:00 PM - 1:00 PM
(3-103) Impact of a Pharmacist-Led Heart Failure (HF) Guideline Directed Medical Therapy Titration Clinic on HF Related Emergency Department Visits and Hospital Readmissions
Favorite
12:00 PM - 1:00 PM
(3-104) Exploring Characteristics of Patients Potentially Eligible for Transition from Warfarin to Direct Oral Anticoagulants: A Descriptive Study in an Anticoagulation Clinic
Favorite
12:00 PM - 1:00 PM
(3-105) Impact of Antimicrobial Cascade Reporting on Broad-Spectrum Antibiotic Use in the Treatment of Gram-Negative Infections
Favorite
12:00 PM - 1:00 PM
(3-106) Utility of Direct Oral Anticoagulants (DOACs) in the Treatment of Pediatric Venous Thromboembolism (VTE)
Favorite
12:00 PM - 1:00 PM
(3-107) Blood Factor Utilization Evaluation in Cardiovascular Surgery
Favorite
12:00 PM - 1:00 PM
(3-108) Impact of Vial Splitting on Sugammadex Utilization and Spending
Favorite
12:00 PM - 1:00 PM
(3-109) The impact of PGx testing for HLA-B*57:01 when using Abacavir
Favorite
12:00 PM - 1:00 PM
(3-110) Outcomes from IPE Crossover Master of Athletic Training Core Content and PharmD Elective Courses
Favorite
12:00 PM - 1:00 PM
(3-111) Empiric Vancomycin Dosing in Pediatric Patients at a Community Hospital in Northern Indiana
Favorite
12:00 PM - 1:00 PM
(3-112) Pharmacy Education Technology with Artificial Intelligence: Revolutionizing Student Feedback Analysis for Optimizing Pharmacy Education and Instruction.
Favorite
12:00 PM - 1:00 PM
(3-113) Evaluation of a Charitable Medication Access Program and Healthcare Resource Utilization in an Urban Academic Medical Center
Favorite
12:00 PM - 1:00 PM
(3-114) Evaluating the Use of Double Anerobic Coverage Within a Critical Access Hospital
Favorite
12:00 PM - 1:00 PM
(3-115) Retrospective Analysis of Titration of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Beta-Blockers in Patients Post Acute Myocardial Infarction
Favorite
12:00 PM - 1:00 PM
(3-116) Medication Use Evaluation of Phytonadione at a Community Hospital in Northern Indiana
Favorite
12:00 PM - 1:00 PM
(3-117) Service evaluation into the use of inclisiran across North East London in a pharmacist led clinic at St Bartholomew’s Hospital (SBH)
Favorite
12:00 PM - 1:00 PM
(3-118) Empowering Patients Living with Hypertension: Patients’ Perceptions and Acceptability of Home Blood Pressure Monitoring in a Federally Qualified Health Center
Favorite
12:00 PM - 1:00 PM
(3-119) Impact of an Accountable Care Organization Pharmacy Team’s Outreach for Statin Use in Patients with Diabetes or Cardiovascular Disease: A Retrospective Analysis
Favorite
12:00 PM - 1:00 PM
(3-120) Rivaroxaban Adherence for Venous Thromboembolism Prophylaxis in Hospitalized Patients with Sickle-Cell Disease
Favorite
12:00 PM - 1:00 PM
(3-121) Evaluation of Appropriate Monitoring and Management of Digoxin
Favorite
12:00 PM - 1:00 PM
(3-122) Single Center Evaluation of Remodulin/Flolan for Pulmonary Arterial Hypertension Treatment
Favorite
12:00 PM - 1:00 PM
(3-123) Examining Deviations from Intravenous Vancomycin Protocol in Adult Patients
Favorite
12:00 PM - 1:00 PM
(3-124) Minimization of Caregiver Impact with the Use of Ribavirin in Non-Solid Dosage Forms
Favorite
12:00 PM - 1:00 PM
(3-125) Systematic Review of Machine Learning Technology to Identify Patients at Risk for Adverse Medication Events
Favorite
12:00 PM - 1:00 PM
(3-126) Impact of Supervised Advanced Prescribing Practices on Key Performance Indicators (KPIs) for Lung Systemic Anticancer Therapy (SACT)
Favorite
12:00 PM - 1:00 PM
(3-127) Assessing Appropriateness of Liposomal Bupivacaine for Treatment of Post-Surgical Pain
Favorite
12:00 PM - 1:00 PM
(3-128) Characterizing Interventions to Support Caregivers Managing Medications and Feeding for Medically Complex Children-A Scoping Review
Favorite
12:00 PM - 1:00 PM
(3-129) Assessment of As Needed Pain Medication Utilization in an Academic Medical Center: A Descriptive Review
Favorite
12:00 PM - 1:00 PM
(3-130) Assessment and Exploration of Whole Brain Preferences and Communication Styles of Student Pharmacists Participating in International Advanced Pharmacy Practice Experience in Medellin, Colombia
Favorite
12:00 PM - 1:00 PM
(3-131) Health Education Needs Assessment: Education and Implementation at an Innovation Center for Street Youth in Eldoret, Kenya
Favorite
12:00 PM - 1:00 PM
(3-132) The Application of Psychostimulants for Methamphetamine Use Disorder in a Public Health Setting: A Case Series Review
Favorite
12:00 PM - 1:00 PM
(3-133) Evaluating the Appropriateness and Utilization of a Pharmacist Referral Service for the Prescribing of Nirmatrelvir/Ritonavir in Outpatient Settings
Favorite
12:00 PM - 1:00 PM
(3-134) PREVENT and ASCVD Risk Calculators: Estimating 10-Year and 30-Year Patient Risk and Impact on Treatment Recommendations
Favorite
12:00 PM - 1:00 PM
(3-135) Evaluating the Impact of a Virtual Post-Acute Myocardial Infarction (AMI) Clinic in Lipid Management
Favorite
12:00 PM - 1:00 PM
(3-136) Safety and Efficacy of Full Intensive Phase Apixaban and Rivaroxaban following Extended Duration Parenteral Anticoagulation for the treatment of Acute Venous Thromboembolism
Favorite
12:00 PM - 1:00 PM
(3-137) Vitamin K Medication Use Evaluation at a Large Community Health System.
Favorite
12:00 PM - 1:00 PM
(3-138) Pegfilgrastim Administration via Prefilled Syringe vs. On-body Injector in Pediatric Patients
Favorite
12:00 PM - 1:00 PM
(3-139) Comprehensive Analysis of Pain Management Strategies in the Adult Critical Care Unit (ACCU) Following Cardiac Surgery at a Cardiac Specialty Hospital in London, UK
Favorite
12:00 PM - 1:00 PM
(3-140) Riley Maternity Tower Perinatal Headache Management: Medication Usage Review
Favorite
12:00 PM - 1:00 PM
(3-141) Enhancing Pharmacists’ Drug Consultation Services: Outcomes of an EPA-Based Outpatient Counseling Training Program
Favorite
12:00 PM - 1:00 PM
(3-142) Evaluation of Belimumab (Benlysta®) use in Daegu Catholic University Medical Center (DCUMC)
Favorite
12:00 PM - 1:00 PM
(3-143) Analysis of Dispensing Errors after Implementation of Intelligent Mobile Dispensing Management System: 7 Years Later
Favorite
12:00 PM - 1:00 PM
(3-144) Exploration of the Mechanism Underlying Muscle Sensitivity to Oxidative Atrophy in Chronic Kidney Disease
Favorite
12:00 PM - 1:00 PM
(3-145) Performance improvement of a natural language processing system to extract information from patients' complaints in pharmacist records -Effects of additional training using community pharmacy data-
Favorite
12:00 PM - 1:00 PM
(3-146) Optimizing Anticoagulation Therapy in Saudi Arabia: The Evaluation of Pharmacist-Led Interventions on Physician Acceptance and Patient Care
Favorite
12:00 PM - 1:00 PM
(3-147) Real-World Evaluation of the Safety and Effectiveness of Dapagliflozin in the Management of Type 2 Diabetes Mellitus: A Two-Center Retrospective Cohort Study
Favorite
12:00 PM - 1:00 PM
(3-148) Reducing Inappropriate Proton Pump Inhibitors (PPIs) Prescriptions by Implementing Deprescribing Strategies Among Geriatric Patients in Home Healthcare Settings (HHC)
Favorite
12:00 PM - 1:00 PM
(3-150) Establishment of Guidelines for ‘Antibiotic Skin Test(AST)’ to Ensure Safe Use of Antibiotics
Favorite
12:00 PM - 1:00 PM
(3-152) Expansion of ScriptCenter Prescription Locker Service for Patient Pick-Up at the Johns Hopkins Bayview Community Pharmacies
Favorite
12:00 PM - 1:00 PM
(3-153) Utilizing pharmacogenomic tests to optimize pain management therapy in patients with rheumatological conditions at the Ambulatory Clinics of the University of Puerto Rico.
Favorite
12:00 PM - 1:00 PM
(3-154) The Diabetes Distress Scale and the Effects on Management of Glycemic Control
Favorite
12:00 PM - 1:00 PM
(3-155) Assessing Health Literacy in Patients with Diabetes
Favorite
12:00 PM - 1:00 PM
(3-156) Doxorubicin Treatment Enhances B-Raf Degradation in Human Cancer Cells
Favorite
12:00 PM - 1:00 PM
(3-157) Evaluation of Vancomycin Dosing in Larger Adolescents and Young Adults
Favorite
12:00 PM - 1:00 PM
(3-158) Micro-credentials in Pharmacy Education
Favorite
12:00 PM - 1:00 PM
(3-159) Evaluation of Pharmacy Specialist Involvement in the Medication Appeal Process at an Academic Medical Center
Favorite
12:00 PM - 1:00 PM
(3-160) Use of Guideline-Directed Heart Failure Therapy in Patients Using University of Iowa Health Care Pharmacy Services
Favorite
12:00 PM - 1:00 PM
(3-161) Evaluating Patient Eligibility of Switching from Warfarin to a Direct Oral Anticoagulant in an Anticoagulation Case Management Service
Favorite
12:00 PM - 1:00 PM
(3-162) Evaluation of Pharmacist versus Physician Led Inpatient Warfarin Management
Favorite
12:00 PM - 1:00 PM
(3-163) Evaluation of Cephalosporin Allergies in Obstetric Patients
Favorite
12:00 PM - 1:00 PM
(3-164) Impact of Corticosteroid Use on Patient Outcomes in Individuals with Influenza and Lung Disease
Favorite
12:00 PM - 1:00 PM
(3-165) Impact of Biologic Therapy on Inhaled Corticosteroid Dosing in Severe Asthma: A Retrospective Chart Review
Favorite
12:00 PM - 1:00 PM
(3-166) Assessing the Administration of Tranexamic Acid for Trauma Patients Presenting to a Community Hospital Emergency Department
Favorite
12:00 PM - 1:00 PM
(3-167) Characterization of Bacterial Cultures in Sepsis Patients Presenting to an Academic Medical Center
Favorite
12:00 PM - 1:00 PM
(3-168) Assessment of Oral Immunoglobulin Therapy in Managing Norovirus-Associated Diarrhea in Pediatric Kidney Transplant Recipients
Favorite
12:00 PM - 1:00 PM
(3-169) Evaluation of Specialty Pharmacy Efficiency in Patient Outreach After Implementation of Texting Platform
Favorite
12:00 PM - 1:00 PM
(3-170) Subcutaneous semaglutide overdose: a case report and literature review
Favorite
12:00 PM - 1:00 PM
(3-171) Assessing Steroid-Sparing Premedication De-escalation in Paclitaxel Regimens
Favorite
12:00 PM - 1:00 PM
(3-172) Comparison of Dextrose 10% and Dextrose 50% Boluses in the Prevention of Iatrogenic Hypoglycemia Following Intravenous Insulin for Hyperkalemia
Favorite
12:00 PM - 1:00 PM
(3-173) Palonosetron: A Medication- Use Evaluation at an Academic Medical Center
Favorite
12:00 PM - 1:00 PM
(3-174) Rituximab Medication-Use Evaluation at an Academic Medical Center
Favorite
12:00 PM - 1:00 PM
(3-175) Terlipressin Usage: A Medication-Use Evaluation at an Academic Medical Center
Favorite
12:00 PM - 1:00 PM
(3-176) Upadacitinib Prescribing Practices: A Medication-Use Evaluation at The University of Kansas Health System
Favorite
12:00 PM - 1:00 PM
(3-177) Evaluation of Antibiogram versus Patient-Specific Risk Factor Pathway to Optimize Empiric Antibiotic Therapy for Gram-Negative Bacterial Pneumonia in the Intensive Care Unit
Favorite
12:00 PM - 1:00 PM
(3-178) Evaluation of Single-Dose Gentamicin for Uncomplicated Urinary Tract Infections in the Emergency Department
Favorite
12:00 PM - 1:00 PM
(3-179) Assessing Levetiracetam Prophylaxis for Neurocritical Care: Insights from a Community Hospital
Favorite
12:00 PM - 1:00 PM
(3-180) Evaluation of Dornase Alfa Use Within a Pediatric Institution
Favorite
12:00 PM - 1:00 PM
(3-181) The Multivitamin Mystery: A Medication-Use Evaluation at a Major Medical Center
Favorite
12:00 PM - 1:00 PM
(3-182) Evaluating Blood Culture Identification Results
Favorite
12:00 PM - 1:00 PM
(3-183) Examination of opioid use in robot-assisted versus manual total knee arthroplasty
Favorite
12:00 PM - 1:00 PM
(3-184) Pharmacogenomics Implementation Plan for Sertraline and CYP2C19 in Retail Pharmacy
Favorite
12:00 PM - 1:00 PM
(3-185) Evaluation of Sedation in Critically Ill Pregnant Patients
Favorite
12:00 PM - 1:00 PM
(3-186) Analysis of Intravenous to Oral Antibiotic Conversion of Doxycycline in a Community Hospital
Favorite
12:00 PM - 1:00 PM
(3-187) Aprepitant Medication Use Evaluation at an Academic Medical Center
Favorite
12:00 PM - 1:00 PM
(3-188) Medication Use Evaluation of Intravenous Aprepitant for the Prevention of Post-operative Nausea and Vomiting (PONV) in Patients Undergoing Bariatric Surgery
Favorite
12:00 PM - 1:00 PM
(3-189) Assessing Third-Year Pharmacy Students' Performance in Journal Club Milestones: A 2023-2024 Comparison
Favorite
12:00 PM - 1:00 PM
(3-190) Evaluating the impact of significant relationship status on career plans among PharmD students and residents.
Favorite
12:00 PM - 1:00 PM
(3-191) Evaluation of an Insulin Infusion Protocol in Laboring Patients
Favorite
12:00 PM - 1:00 PM
(3-192) Development of Pharmacy Technician Advancement Program for an Academic Medical Center
Favorite
12:00 PM - 1:00 PM
(3-193) Evaluation of Ceftriaxone Optimization
Favorite
12:00 PM - 1:00 PM
(3-194) Blood pressure control in patients with type 2 diabetes: a retrospective chart review of patients at a family medicine clinic in rural Kentucky
Favorite
12:00 PM - 1:00 PM
(3-195) Evaluation of Injectable Promethazine in the Ambulatory Setting at an Academic Health System
Favorite
12:00 PM - 1:00 PM
(3-196) Utilization of Guideline-Directed Medical Therapy (GDMT) in HeartMate 3™ Patients: a single center cohort study
Favorite
12:00 PM - 1:00 PM
(3-197) Daptomycin Pneumonitis Secondary to the Treatment of Osteomyelitis – A Case Report
Favorite
12:00 PM - 1:00 PM
(3-198) Stability of Naloxone Solutions in Normal Saline and 5% Dextrose in Water
Favorite
12:00 PM - 1:00 PM
(3-199) Factitious Hypoglycemia In Pregnancy: A Case Report
Favorite
12:00 PM - 1:00 PM
(3-200) Frequency and Characteristics of Healthcare Encounters in the Week Preceding Incident Sepsis Hospitalization: A Nationwide Observational Analysis
Favorite
12:00 PM - 1:00 PM
(3-201) Impact of Standard Versus Weight-based Maintenance Dosing of Fosphenytoin on Achieving Therapeutic Levels
Favorite
12:00 PM - 1:00 PM
(3-202) Sodium Balance in Hyponatremic Patients Receiving Custom Dilution Continuous Renal Replacement Therapy Fluids
Favorite
12:00 PM - 1:00 PM
(3-203) Evaluation of Opioid Dose Post-discharge in Orthopedic Trauma or Major Trauma Patients
Favorite
12:00 PM - 1:00 PM
(3-204) Patients Assessed for Hepatitis C Virus in the Emergency Department Have Discordant Fibrosis-4 and Transient Elastography Measurements
Favorite
12:00 PM - 1:00 PM
(3-205) Understanding the Impact of Pharmacist Prescriptive Authority on State Level PrEP Access
Favorite
12:00 PM - 1:00 PM
(3-206) Liposomal Bupivacaine Usage for Shoulder Arthroplasty and Rotator Cuff Repair at a Regional Teaching Hospital
Favorite
12:00 PM - 1:00 PM
(3-207) Enhancing Readiness for Acute Care Inpatient Advanced Pharmacy Practice Experiences (APPEs) Through Use of a Mini-Video Library: A Quality Improvement Project
Favorite
12:00 PM - 1:00 PM
(3-208) Stability Study to Clarify the Stability of Meropenem at Room Temperature
Favorite
12:00 PM - 1:00 PM
(3-209) Assessing Ulcerative Colitis Risk Modifiers in Patients Living in Appalachia
Favorite
12:00 PM - 1:00 PM
(3-210) Effects of Typical Antipsychotics Administration in Methamphetamine Exposed Patients in the Emergency Department: A Retrospective Cohort Study
Favorite
12:00 PM - 1:00 PM
(3-211) Impact of Quadruple mTOR-based Immunosuppression on Infection Outcomes in Lung Transplant Recipients
Favorite
12:00 PM - 1:00 PM
(3-212) Inpatient Use of Oral Extended-Release Opioids
Favorite
12:00 PM - 1:00 PM
(3-213) Evaluating the Appropriate Use of Pharmacy Calculations by Artificial Intelligence Models
Favorite
12:00 PM - 1:00 PM
(3-214) Off-label Use of Cabotegravir/Rilpivirine in a Patient Requiring Injectable Antiretrovirals
Favorite
12:00 PM - 1:00 PM
(3-215) Shifting Perspectives: Assessing Knowledge and Beliefs in Harm Reduction Strategies Among Future Healthcare Professionals – H.E.R.O. Harm Reduction and Opioid Education
Favorite
12:00 PM - 1:00 PM
(3-216) Pharmacy Adherence to Best Practices When Dispensing Liquid Medications for Children
Favorite
12:00 PM - 1:00 PM
(3-217) The Evaluation of Four-Factor Prothrombin Complex Concentrates Utilization Following a Formulary Preference Change at the Largest Academic Medical Center in Louisiana
Favorite
12:00 PM - 1:00 PM
(3-218) The Impact of Emergency Medicine Clinical Pharmacist Led Education on Nursing at a Level 2 Trauma Center
Favorite
12:00 PM - 1:00 PM
(3-219) Elevating Diabetes Education: Exploring Perceptions and Barriers of Patients to Diabetes Education in an Underserved Community
Favorite
12:00 PM - 1:00 PM
(3-220) Vasopressor Medication Use Evaluation: Vasopressor Use Through Peripheral Line Prior To Policy Initiation
Favorite
12:00 PM - 1:00 PM
(3-221) Evaluation of Intravenous Levothyroxine Use After Implementation of Restriction Criteria
Favorite
12:00 PM - 1:00 PM
(3-222) Evaluation of Fusarium Solani Osteomyelitis
Favorite
12:00 PM - 1:00 PM
(3-223) Evaluation of Plasmodium falciparum Malaria in the Presence of a Possible Coinfection
Favorite
12:00 PM - 1:00 PM
(3-224) Evaluation of an Our Practice Alert to Improve Apixaban Dosing Consistent with Prescribing Information in Patients with Non-valvular Atrial Fibrillation at an Academic Medical Center
Favorite
12:00 PM - 1:00 PM
(3-225) Managing CNS parasitic infections: A case of neurocysticercosis
Favorite
12:00 PM - 1:00 PM
(3-226) A College of Pharmacy Tele-Based Approach to Addressing Health Equity
Favorite
12:00 PM - 1:00 PM
(3-227) Correlation Analysis Between Fall and Fracture Occurrence in the Elderly Diabetic Population and Comorbid Conditions: a Quantitative Study
Favorite
12:00 PM - 1:00 PM
(3-228) Evaluating the Effectiveness and Safety of Direct Oral Anticoagulants (DOACs) Compared to Warfarin in Obese and Morbidly Obese Patients Taking Nonsteroidal Anti-inflammatory drugs (NSAIDs)
Favorite
12:00 PM - 1:00 PM
(3-229) Evaluation of Direct Acting Oral Anticoagulant Dosing and Duration in the Treatment of Venous Thromboembolism
Favorite
12:00 PM - 1:00 PM
(3-230) Clinical Trial Participation in the Gulf South: Assessing Awareness, Willingness and Barriers Among Minority Communities
Favorite
12:00 PM - 1:00 PM
(3-231) Socioeconomic Characteristics, Healthcare Trust, and Willingness to Participate in Clinical Trials Among Minority Populations in New Orleans
Favorite
12:00 PM - 1:00 PM
(3-232) Idiopathic and metabolic triggers leading to recurrent acute pancreatitis in a 30-year- old woman
Favorite
12:00 PM - 1:00 PM
(3-233) Redefining Patient Care: The Importance of Pharmacist-Led Initiatives in Enhancing Patient Advocacy
Favorite
12:00 PM - 1:00 PM
(3-234) A retrospective evaluation on the use of ENTRESTO® (sacubitril/valsartan) for heart failure at an academic hospital
Favorite
12:00 PM - 1:00 PM
(3-235) Bridging the Gap: Addressing Racial Disparities in Treatment Outcomes for Second-Degree Heart Block
Favorite
12:00 PM - 1:00 PM
(3-236) Risk of Recurrent Arrhythmias in Patients Receiving Amiodarone for New Onset Atrial Fibrillation in Critical Illness
Favorite
12:00 PM - 1:00 PM
(3-237) A Medication Use Evaluation of Calcitonin Restriction Guideline for Use in an Academic Hospital
Favorite
12:00 PM - 1:00 PM
(3-238) Evaluation of Antibiotic Prophylaxis in Patients admitted to University Medical Center New Orleans with Traumatic Facial Fractures
Favorite
12:00 PM - 1:00 PM
(3-239) In vitro Evaluation of Synthetic Polyphenol against SARS-CoV-2
Favorite
12:00 PM - 1:00 PM
(3-240) Evaluating the Impact of Remote Oncology Clinical Services
Favorite
12:00 PM - 1:00 PM
(3-241) Prior Authorizations: A Barrier to Lower Limb Revascularization in Peripheral Artery Disease
Favorite
12:00 PM - 1:00 PM
(3-242) Enteral Phosphate Repletion in Patients Receiving Continuous Renal Replacement Therapy
Favorite
12:00 PM - 1:00 PM
(3-243) Cost-Savings with Common Stock Insulin Vials
Favorite
12:00 PM - 1:00 PM
(3-244) Multi-year analysis of prescribing card implementation effectiveness at an express care center for first-line antibiotic therapy prescribing for uncomplicated cystitis
Favorite
12:00 PM - 1:00 PM
(3-245) Outcomes of Postgraduate Training Elective Course for Third-Year Student Pharmacists
Favorite
12:00 PM - 1:00 PM
(3-246) Frequency of Adverse Drug Events (ADEs) Due to Unexpected Reactions from GIP/GLP-1 Agonist and GLP-1 Agonists Used for Weight Loss
Favorite
12:00 PM - 1:00 PM
(3-247) Development of a ssDNA-based Sensing Platform for Environmental Toxicology
Favorite
12:00 PM - 1:00 PM
(3-248) Appropriate Indication of Long-Term Aspirin for Patients on Concurrent Warfarin Therapy at a Baltimore City Community Hospital Anticoagulation Clinic
Favorite
12:00 PM - 1:00 PM
(3-249) Enhancing Pneumococcal Vaccination Rates: Analysis of a Targeted Outreach Strategy in Patients with Type 2 Diabetes
Favorite
12:00 PM - 1:00 PM
(3-250) Biochemical changes underlying the neuroendocrine differentiation of prostate cancer cells.
Favorite
12:00 PM - 1:00 PM
(3-251) Evaluation of Service Implementation for High Resolution Anoscopy (HRA) in a Rural Clinic to Prevent Anal Cancer
Favorite
12:00 PM - 1:00 PM
(3-252) Impact of a Pharmacist-Led Medications of Abuse Review Program in Correctional Facilities
Favorite
12:00 PM - 1:00 PM
(3-253) Declining Pharmacy School Enrollment: Challenges and Opportunities of Provider Status
Favorite
12:00 PM - 1:00 PM
(3-254) Cost Effectiveness of Conversion From Tenofovir Alafenamide (TAF)-Based Regimen To A Two Drug Regimen Program In Correctional Facilities
Favorite
12:00 PM - 1:00 PM
(3-255) Niosomal Encapsulation of Curcumin for Overcoming Multidrug Resistance in Ovarian Cancer
Favorite
12:00 PM - 1:00 PM
(3-256) Synthesis of Trifluoromethylated Cyclic Enaminone Intermediate: Early Drug Discovery of Antiseizure Agents for Treatment of Refractory Epilepsy
Favorite
12:00 PM - 1:00 PM
(3-257) Evaluating the Economic Impact of Reducing HbA1c Levels in Patients with Diabetes
Favorite
12:00 PM - 1:00 PM
(3-258) Role of the Child Opportunity Index in Understanding Disparities in Healthcare Among Pediatric Populations
Favorite
12:00 PM - 1:00 PM
(3-259) Medication use evaluation of surgery prophylaxis antibiotic administration, selection, and timing at a small community hospital
Favorite
12:00 PM - 1:00 PM
(3-260) A retrospective medication use evaluation of appropriate piperacillin-tazobactam scheduling and administration following a loading dose
Favorite
12:00 PM - 1:00 PM
(3-261) Implementation of ScriptCenter Automation in a Federal Hospital Setting
Favorite
12:00 PM - 1:00 PM
(3-262) Optimizing Pharmacist Team Integration For Pediatric Intensive Care Unit Patient Management
Favorite
12:00 PM - 1:00 PM
(3-263) Optimizing Pharmacist Team-Integration for ICU Patient Management (OPTIM): Patient Outcomes Focusing on the Neonatal ICU Population.
Favorite
12:00 PM - 1:00 PM
(3-264) Terbutaline Continuous Infusion for Pediatric Status Asthmaticus: A Retrospective Chart Review
Favorite
12:00 PM - 1:00 PM
(3-265) Alteplase vs Tenecteplase in Acute Ischemic Stroke
Favorite
12:00 PM - 1:00 PM
(3-266) Oncology Patient Perspectives on Medical Cannabis Use in Maryland
Favorite
12:00 PM - 1:00 PM
(3-267) Quantifying nephrotoxin burden among hospitalized patients diagnosed with hospital-acquired acute kidney injury (HA-AKI) at an urban academic medical center.
Favorite
12:00 PM - 1:00 PM
(3-268) Clinical Evaluation of G-CSF Use in R-MPV for CNS Lymphoma
Favorite
12:00 PM - 1:00 PM
(3-269) Better Sleep: Enhancing Sleep Quality in Older Adults through Deprescribing
Favorite
12:00 PM - 1:00 PM
(3-270) Fluoxetine Mitigates Behavioral Alterations Induced by Chronic Mild Stress in Drosophila Melanogaster.
Favorite
12:00 PM - 1:00 PM
(3-271) Impact of the Federal Controlled Substances Act on Opioid Prescription Management in New England States: A Comparative Analysis
Favorite
12:00 PM - 1:00 PM
(3-272) Shifting Diagnoses: A Case Report on the Detection and Management of Group A Streptococcal Bacteremia in a Postpartum Patient initially thought to have Sacroiliitis
Favorite
12:00 PM - 1:00 PM
(3-273) Implementation of Evolocumab in a Patient with Type 2 Diabetes and Underlying Atherosclerotic Cardiovascular Disease
Favorite
12:00 PM - 1:00 PM
(3-274) Improving Glycemic Control in Older Adults with Type 2 Diabetes Using 4-Day Insulin Patch for Mealtime Insulin Evidenced by Continuous Glucose Monitoring: A Case Report
Favorite
12:00 PM - 1:00 PM
(3-275) Optimizing Type 2 Diabetes Management in an Ambulatory Care Setting: Efficacy of GLP-1 RA and Basal Insulin Combination
Favorite
12:00 PM - 1:00 PM
(3-276) Osteoporosis: Know Bones About It
Favorite
12:00 PM - 1:00 PM
(3-277) Pesticides: From The Farm To The Fork/What Are We Eating?
Favorite
12:00 PM - 1:00 PM
(3-278) Review of the association between cannabis use and development of type 2 diabetes mellitus
Favorite
12:00 PM - 1:00 PM
(3-279) Screening for Autoantibodies and Distinguishing Between Type 1 Diabetes and Type 2 Diabetes: The Role of the Pharmacist
Favorite
12:00 PM - 1:00 PM
(3-280) Semaglutide-Associated Depressive Symptoms: A Case report Highlighting Potential Mental Health Adverse Effects in a patient treated for Obesity
Favorite
12:00 PM - 1:00 PM
(3-281) Weight Management with Semaglutide in U.S. Adults: Projected Impact on Obesity Prevalence and Heart Failure Risk
Favorite
12:00 PM - 1:00 PM
(3-282) Quest in compounding new parasite-killing drugs
Favorite
12:00 PM - 1:00 PM
(3-283) Clinical and operational impact of a pharmacist on a new hospital at home unit in a community hospital setting
Favorite
12:00 PM - 1:00 PM
(3-284) Inpatient Management of Metformin-induced Lactic Acidosis: A Case Report
Favorite
12:00 PM - 1:00 PM
(3-285) Torsades De Pointes After Bradycardia During Dexmedetomidine Infusion: A Case Report
Favorite
12:00 PM - 1:00 PM
(3-286) Navigating the Digital Landscape: Health Literacy in Accessible Online Content for Tirzepatide for Weight Loss
Favorite
12:00 PM - 1:00 PM
(3-287) Oral Contraceptives and GLP-1 Receptor Agonists
Favorite
12:00 PM - 1:00 PM
(3-288) Reevaluating Gabapentin Use in Geriatric Population: Risk, Opioids, and the Path Forward
Favorite
12:00 PM - 1:00 PM
(3-289) Is Ceftriaxone 2 grams Preferred over 1 gram in Patients with Gram-negative Bacteremia?
Favorite
12:00 PM - 1:00 PM
(3-290) Quality Improvement Initiative to Enhance Nurse Engagement in Antibiotic Stewardship
Favorite
12:00 PM - 1:00 PM
(3-291) Modified Chronic Mild Stress Paradigm for Assessing Stress-Related Behavioral Alterations in Drosophila Melanogaster
Favorite
12:00 PM - 1:00 PM
(3-292) Physiological Improvements of Alzheimer’s Disease in First Animal Study Using Novel Compounds
Favorite
12:00 PM - 1:00 PM
(3-293) Lysine Methyltransferase 2C Mutation Patterns and Hemostasis Pathway Dysregulation are Associated with 5-Fluorouracil Responsiveness in Pancreatic Cancer
Favorite
12:00 PM - 1:00 PM
(3-294) Shining a Light on Melanoma: Addressing Disparities in Skin of Color for Better Health Outcomes
Favorite
12:00 PM - 1:00 PM
(3-295) Number of PharmDs Entering Industry Upon Graduation from 2020-2023
Favorite
12:00 PM - 1:00 PM
(3-296) Impact of a Board-Certified Psychiatric Pharmacist Integrated into a Team-Based Outpatient Psychiatry Clinic
Favorite
12:00 PM - 1:00 PM
(3-297) Establishing Proportion of Days Covered Benchmarks for Health System Specialty Pharmacy Clinical Outcomes Evaluation
Favorite
12:00 PM - 1:00 PM
(3-298) Case Report: Diabetic Patient with Sickle Cell Anemia
Favorite
12:00 PM - 1:00 PM
(3-299) Impact of Glucagon-Like Peptide-1 Receptor Agonists on Weight Changes in Antipsychotic-Treated Patients with Type 2 Diabetes Mellitus
Favorite
12:00 PM - 1:00 PM
(3-300) Managing Hypoglycemia in a Patient with Elevated A1C and Hypoglycemia Unawareness Using a Continuous Glucose Monitoring System: A Case Report
Favorite
12:00 PM - 1:00 PM
(3-301) Efficacy and Safety of Paxlovid in Reducing Hospitalizations and Severe Outcomes in High-Risk COVID-19 Patients: A Comprehensive Review
Favorite
12:00 PM - 1:00 PM
(3-302) Shedding Light on Medication Errors and IV Light-Protection Bags
Favorite
12:00 PM - 1:00 PM
(3-303) Targeting Glycosylation in Lymphoma: Implications for Drug Therapy
Favorite
12:00 PM - 1:00 PM
(3-304) Impact of Implementing MRSA Nares Screening on Perioperative Vancomycin Usage in Surgical Patients: A Comparative Pre- and Post-Implementation Study
Favorite
12:00 PM - 1:00 PM
(3-305) Treating Urinary Tract Infection (UTI) and Treatment-Resistant Depression in the Setting of Multidrug-Resistant Infection and Drug-Drug Interaction: A Focus on Methylphenidate and Linezolid Interaction
Favorite
12:00 PM - 1:00 PM
(3-306) Evaluating the role of Artificial Intelligence (AI) Tools in Drug Information Retrieval
Favorite
12:00 PM - 1:00 PM
(3-307) Impact of Semaglutide on Alcohol Consumption : A Case Report of Dual Benefits in Weight Loss and Alcohol Reduction
Favorite
12:00 PM - 1:00 PM
(3-308) Bridging Psychiatry and Pharmacogenomics: A Comprehensive Review of Pharmacogenomics Implementation in Psychiatry Clinical Practice
Favorite
12:00 PM - 1:00 PM
(3-309) Atorvastatin-Induced Hypersensitivity Following Dose Escalation in an Adult Female - Case Report
Favorite
12:00 PM - 1:00 PM
(3-310) Assessing the Impact of Concomitant Use of Sulfonylureas with Glucagon-Like Peptide-1 Receptor Agonists on Weight Loss
Favorite
12:00 PM - 1:00 PM
(3-311) Literature Review of Secondary Antibody Mediated Response to Non-Toxic Accessory Proteins(NAPs) in Non-Cosmetic Botulinum Toxin A(BoNt-A) Formulations
Favorite
12:00 PM - 1:00 PM
(3-312) Retrospective Analysis of Oxybutynin Use in Patients Aged 65 and Older Admitted in a Community Hospitals Group
Favorite
12:00 PM - 1:00 PM
(3-313) Comparative Evaluation of Lupron Depot and Levonorgestrel IUDs in the Management of Endometriosis: A Literature Review
Favorite
12:00 PM - 1:00 PM
(3-314) Review of Low-Dose Naltrexone for the Treatment of Fibromyalgia
Favorite
12:00 PM - 1:00 PM
(3-315) Patient Case Report: Optimizing Diabetes Care in the Elderly; Deprescribing Metformin for a 99-year-old with Chronic Kidney Disease
Favorite
12:00 PM - 1:00 PM
(3-316) Evaluation of Reduced Dose Intravenous Zoledronic Acid for the Prevention of Secondary Fractures in Hospitalized Adult Patients with Renal Impairment
Favorite
12:00 PM - 1:00 PM
(3-317) Incorporating Pharmacogenomic Data into Pain Management of Ehlers-Danlos Syndrome
Favorite
12:00 PM - 1:00 PM
(3-318) Use of Anti-Inflammatory Reliever Therapy Versus Albuterol Alone for Managing Exercise-Induced Bronchospasm
Favorite
12:00 PM - 1:00 PM
(3-319) Evolution of Diversity in Obesity Clinical Trials: A Century of Ethnic and Racial Representation (1924-2024)
Favorite
12:00 PM - 1:00 PM
(3-320) Pain Management and Harm Reduction Strategies in Hidradenitis Suppurativa
Favorite
12:00 PM - 1:00 PM
(3-321) Managing Psoriasis in a Patient with Psoriatic Flare by Birth Control Initiation: A Case Report
Favorite
12:00 PM - 1:00 PM
(3-322) Investigating the Influence of Glycosylation in Disease Progression and Treatment of Multiple Myeloma
Favorite
12:00 PM - 1:00 PM
(3-323) Risk Assessment for Toxicity in Commonly Used Drugs
Favorite
12:00 PM - 1:00 PM
(3-324) Exploring the Therapeutic Benefit of Glycosylation Inhibitors in Chronic Myeloid Leukemia
Favorite
12:00 PM - 1:00 PM
(3-325) Therapeutic Potential of Inhibiting O-Linked Glycosylation in Acute Lymphoid Leukemia
Favorite
12:00 PM - 1:00 PM
(3-326) Optimizing Biosimilar Policies for Enhanced Healthcare Based on Boston-Area Hospitals
Favorite
12:00 PM - 1:00 PM
(3-327) Assessing remote blood pressure monitoring for the improvement of health care quality in a community-based organization
Favorite
12:00 PM - 1:00 PM
(3-328) Investigating Weight Loss Effects of GLP1 RAs and GLP1/GIP RAs at Boston Medical Center’s Endocrine Clinic Utilizing Clinical Pharmacy Follow-up
Favorite
12:00 PM - 1:00 PM
(3-329) Clinical Outcomes of Potentially Inappropriate Dosing of Direct-Acting Oral Anticoagulants in Older Adults with Atrial Fibrillation
Favorite
12:00 PM - 1:00 PM
(3-330) A Systematic Review of the Impact of Pharmacy-led Transitions of Care Services at Point of Hospital Discharge
Favorite
12:00 PM - 1:00 PM
(3-331) Hookah Smoking Amongst Arab Americans: Cultural Attitudes and Challenges in Culturally Competent Healthcare
Favorite
12:00 PM - 1:00 PM
(3-332) Addressing Medication Access Challenges Due to Shortages: Innovative Solutions from Pharmacy Students
Favorite
12:00 PM - 1:00 PM
(3-333) U.S. opioid prescribing practices after ICU hospitalizations requiring mechanical ventilation
Favorite
12:00 PM - 1:00 PM
(3-334) Anti–Xa Monitoring in Patients Receiving Enoxaparin on General Medicine Floors at an Academic Medical Center
Favorite
12:00 PM - 1:00 PM
(3-335) Evaluation of Tofacitinib and Upadacitinib Inpatient Use at A Large Academic Hospital
Favorite
12:00 PM - 1:00 PM
(3-336) Early Acute Illness Detection in Community-Dwelling Patients with Dementia
Favorite
12:00 PM - 1:00 PM
(3-337) Review of Isavuconazole Use at a Tertiary Academic Medical Center
Favorite
12:00 PM - 1:00 PM
(3-338) Transitioning a Candidemia Patient with Prolonged QTc and Limited Intravenous Central Line Access to Rezafungin
Favorite
12:00 PM - 1:00 PM
(3-339) The Role of Nutrition in Black Pediatric Patients with Sickle Cell Disease
Favorite
12:00 PM - 1:00 PM
(3-340) A Systematic Review of Oncology Clinical Trial Enrollment Barriers from a Health Care Provider Perspective
Favorite
12:00 PM - 1:00 PM
(3-341) Current State of Sleep and Sleep Disorders Education: Survey of Medical Schools
Favorite
12:00 PM - 1:00 PM
(3-342) Creating Drug Discovery Strategies Through Tragedies
Favorite
12:00 PM - 1:00 PM
(3-343) Use of emapalumab for the management of refractory hemophagocytic lymphohistiocytosis in a patient with systemic juvenile idiopathic arthritis
Favorite
12:00 PM - 1:00 PM
(3-344) Characterization of Stress Ulcer Prophylaxis Use After Hospital Discharge in Mechanically Ventilated Intensive Care Unit Adults
Favorite
12:00 PM - 1:00 PM
(3-345) Is Using Ertapenem Susceptibilities as a Surrogate for Meropenem Susceptibilities Viable?
Favorite
12:00 PM - 1:00 PM
(3-346) Consumption of grapes reduces biomarkers indicative of cellular damage promoted by UV irradiation of the skin of human volunteers
Favorite
12:00 PM - 1:00 PM
(3-347) Epigenetic Modulation and Anti-Cancer Properties of Ginger in Neuroblastoma: A Phytochemical Approach to Combat Drug-Resistance
Favorite
12:00 PM - 1:00 PM
(3-348) Safety of Peripheral Amiodarone: Impact of Excipient Removal
Favorite
12:00 PM - 1:00 PM
(3-349) Examining the Clinical Demand for PENFAST Scoring in Patients with Recorded Penicillin Allergies: A Descriptive Report
Favorite
12:00 PM - 1:00 PM
(3-350) Perceived Benefit and Applications of Pharmacogenomics
Favorite
12:00 PM - 1:00 PM
(3-351) Making a Difference: The Impact of Community Service on Pharmacy Students
Favorite
12:00 PM - 1:00 PM
(3-352) Comparing Likelihood and Comfort in Deprescribing Antihypertensives Among Pharmacy Students and Preceptors Across Specific Patient Populations
Favorite
12:00 PM - 1:00 PM
(3-353) Likelihood to Recommend vs Comfort in Deprescribing Proton-Pump Inhibitors Among Third- and Fourth-Year Pharmacy Students and Preceptors
Favorite
12:00 PM - 1:00 PM
(3-354) Comparison of Time Spent in Internalized Normalized Ratio (INR) Goal Range Between Provider-Dosed and Pharmacist-Dosed Warfarin
Favorite
12:00 PM - 1:00 PM
(3-355) Evaluation of Therapy for Hepatorenal Syndrome in Non-Intensive Care Unit Patients: A single-center retrospective chart review
Favorite
12:00 PM - 1:00 PM
(3-356) Retrospective Observational Evaluation of the Rate of Fluid Resuscitation in Acute Pancreatitis
Favorite
12:00 PM - 1:00 PM
(3-357) Evaluation of Azithromycin Dosing for Patients Admitted with Community Acquired Pneumonia
Favorite
12:00 PM - 1:00 PM
(3-358) Comparison of Cefdinir versus Cephalexin Failure Rates in the Treatment of Gram-Negative Bacteremia: A single-center retrospective chart review
Favorite
12:00 PM - 1:00 PM
(3-359) Leveraging Technology to Improve Duration of Antibiotic Therapy in Community Acquired Pneumonia
Favorite
12:00 PM - 1:00 PM
(3-360) Impact of a Newly Implemented Patient-Controlled Analgesia Protocol on Patients Presenting with Sickle Cell Disease to the Acute Care Setting
Favorite
12:00 PM - 1:00 PM
(3-361) Prophylactic Dexamethasone Dosing and Incidence of Hypersensitivity Reactions in the Setting of 3-hour Paclitaxel Infusion Chemotherapy Regimens
Favorite
12:00 PM - 1:00 PM
(3-362) Association Between Maintenance Medication Adherence and the Likelihood of Receiving Antibiotics Among Adults
Favorite
12:00 PM - 1:00 PM
(3-363) Willingness of Individuals to Talk to Community Pharmacists About Their Sexual Health
Favorite
12:00 PM - 1:00 PM
(3-364) Evaluating the treatment of community acquired pneumonia in chronic obstructive pulmonary disease patients: a single-center retrospective chart review
Favorite
12:00 PM - 1:00 PM
(3-365) COMPARE-SBP: Comparative Outcomes in the Management of Prophylactic Antibiotic Regimens for Efficacy in Spontaneous Bacterial Peritonitis: A single-center retrospective chart review
Favorite
12:00 PM - 1:00 PM
(3-366) Tracking Healthcare Effectiveness Data and Information Set measures for Acute Bronchitis with the Collaboration to Harmonize Antimicrobial Registry Measures.
Favorite
12:00 PM - 1:00 PM
(3-367) Use of Collaboration to Harmonize Antimicrobial Registry Measure (CHARM) to Track and Assess the Appropriate Treatment for Upper Respiratory Infection HEDIS Measure (URI)
Favorite
12:00 PM - 1:00 PM
(3-368) Patterns in Initial Dosing of Direct Oral Anticoagulants for Nonvalvular Atrial Fibrillation
Favorite
12:00 PM - 1:00 PM
(3-369) Assessment of Pharmacist Management of a Direct Oral Anticoagulant (DOAC) Dashboard
Favorite
12:00 PM - 1:00 PM
(3-370) Evaluation of Diabetic Testing Supplies Dispensing in the Outpatient Pharmacy at a Large Academic Medical Center
Favorite
12:00 PM - 1:00 PM
(3-371) Influenza and COVID-19 Vaccination Rates in Infants, Children, and Adolescents with Cystic Fibrosis
Favorite
12:00 PM - 1:00 PM
(3-372) Assessment of Renal Dose Adjustments for Psychotropic Medications in Hospitalized Patients
Favorite
12:00 PM - 1:00 PM
(3-373) Use and Monitoring of Lithium in Hospitalized Patients
Favorite
12:00 PM - 1:00 PM
(3-375) What To Do For Graft Versus Host Disease When You Cannot Use Calcineurin Inhibitors
Favorite
12:00 PM - 1:00 PM
(3-376) Survival Benefit of Angiotensin Inhibitors in Black and White Patients with Heart Failure and Ejection Fraction <50%
Favorite
12:00 PM - 1:00 PM
(3-377) Providers’ Perceptions on Pharmacogenetic Testing when Ordered to Assist with Psychotropic Management
Favorite
12:00 PM - 1:00 PM
(3-378) Elucidating the Effect of Chronic Proton Pump Inhibitor Usage Among Patients with COVID-19 Infections
Favorite
12:00 PM - 1:00 PM
(3-379) Evaluation of the Appropriate Use and Dosing of Psychiatric Medications for Mental Health Conditions in Patients with Chronic Liver Disease
Favorite
12:00 PM - 1:00 PM
(3-380) Evaluating the Frequency of Cefepime and Meropenem Dosing Errors in CRRT Patients
Favorite
12:00 PM - 1:00 PM
(3-381) Disparities in Tdap and Shingles Vaccine Receipt by Race and Ethnicity among U.S. Older Adults
Favorite
12:00 PM - 1:00 PM
(3-382) Racial and Ethnic Disparities in Influenza and Pneumococcal Vaccination Rates among US Adults
Favorite
12:00 PM - 1:00 PM
(3-383) Artificial Intelligence for Drug Information: Evaluating Its Use in Real World Pharmacy Practice
Favorite
12:00 PM - 1:00 PM
(3-384) Prescribing Patterns of Sublingual Buprenorphine: Medication Use Evaluation
Favorite
12:00 PM - 1:00 PM
(3-385) Utilization and Perceptions of Annual Wellness Visits by Registered Nurses in an Academic Medical Center
Favorite
12:00 PM - 1:00 PM
(3-386) Optimizing the Empiric Treatment of Urinary Tract Infections in the Emergency Department
Favorite
12:00 PM - 1:00 PM
(3-387) Risk Factors for Ceftazidime/Avibactam-Resistant Extended Beta-Lactam Resistant P. aeruginosa
Favorite
12:00 PM - 1:00 PM
(3-388) The Effect of the 2016 American Psychiatric Association (APA) Practice Guidelines on Antipsychotic Use in Patients with Non-Institutionalized Dementia
Favorite
12:00 PM - 1:00 PM
(3-389) Metabolic Engineering of Moroidin Plant Peptides
Favorite
12:00 PM - 1:00 PM
(3-390) Evaluation of Outpatient Antibiotic Administration through Midline Catheters
Favorite
12:00 PM - 1:00 PM
(3-391) Capecitabine dosing in patients with gastrointestinal malignancies and high body surface area
Favorite
12:00 PM - 1:00 PM
(3-392) Impact of a Pharmacist Driven Intervention on Antimicrobial Surgical Prophylaxis in those with Penicillin and/or Cephalosporin Allergies
Favorite
12:00 PM - 1:00 PM
(3-393) A Look at the Cost-Effectiveness of Dose Rounding Sugammadex in Children
Favorite
12:00 PM - 1:00 PM
(3-394) Impact of HTR3B genotypes on effectiveness of sertraline
Favorite
12:00 PM - 1:00 PM
(3-395) In Vivo Activity of the Dihydropyrimidine Dehydrogenase Enzyme in Patients with Germline Variants in the Dihydropyrimidine Dehydrogenase Gene
Favorite
12:00 PM - 1:00 PM
(3-396) Pharmacogenomic Effects of CYP2C19 and SLC6A4 on Sertraline Efficacy
Favorite
12:00 PM - 1:00 PM
(3-397) Evaluating the Use and Monitoring of Naltrexone in Hospitalized Patients
Favorite
12:00 PM - 1:00 PM
(3-398) Rinvoq Dose De-escalation: Assessing the Incidence of Flare Ups in Patients on Rinvoq for Ulcerative Colitis and Crohn's Disease
Favorite
12:00 PM - 1:00 PM
(3-399) Evaluation of Cytomegalovirus Infection in Moderate vs High Risk Kidney Transplant Recipients Who Received Delayed Valganciclovir Prophylaxis
Favorite
12:00 PM - 1:00 PM
(3-400) Evaluation of the cytomegalovirus (CMV) treatment guidelines for liver transplant recipients at the University of Michigan Health System (UMHS)
Favorite
12:00 PM - 1:00 PM
(3-401) New Onset Diabetes Mellitus in Relation to Tacrolimus Exposure in Solid Organ Transplant
Favorite
12:00 PM - 1:00 PM
(3-402) Antithrombotic Reversal in Intracranial Hemorrhage in the Emergency Department
Favorite
12:00 PM - 1:00 PM
(3-403) The effects of alcohol on crash avoidance reaction time in a driving simulator task: The current drunk driving BAC cut-off (0.08%) is too high.
Favorite
4:15 PM - 5:15 PM
(5-001) Psychotropic Medication Usage in a Residential Treatment Center for Children and Adolescents: A Retrospective Study
Favorite
4:15 PM - 5:15 PM
(5-002) Parent and Caregiver Pediatric Vaccination Administration Hesitancy in an Independent Community Pharmacy Setting
Favorite
4:15 PM - 5:15 PM
(5-003) Evaluation of Nebulized Amikacin to Prevent Pneumonia in Patients on Invasive Mechanical Ventilation : A Case Series
Favorite
4:15 PM - 5:15 PM
(5-004) Assessing Intravenous Methocarbamol Administration in Comparison to Package Insert Recommendations
Favorite
4:15 PM - 5:15 PM
(5-005) Recurrent Clozapine-Induced Pneumonia: Case Report
Favorite
4:15 PM - 5:15 PM
(5-006) Chasing the Zebra! Unexplained Glycemic Stability after Insulin Discontinuation in Long-Standing Type 2 Diabetes Mellitus
Favorite
4:15 PM - 5:15 PM
(5-007) Navigating Antithrombin III Deficiency: Essential Insights for Patient Care
Favorite
4:15 PM - 5:15 PM
(5-008) Development of Relative Value Units for Inpatient Clinical Pharmacy Services
Favorite
4:15 PM - 5:15 PM
(5-009) Characteristics of Inpatients Receiving Dalbavancin
Favorite
4:15 PM - 5:15 PM
(5-010) Difference in Response Time to Beta-Lactam Antibiotics Among Obese and Non-Obese Patients
Favorite
4:15 PM - 5:15 PM
(5-011) Disseminated Strongyloidiasis in an Immigrant Woman with Adult T-Cell Leukemia Lymphoma
Favorite
4:15 PM - 5:15 PM
(5-012) Going Through Trough Times: An Evaluation of Vancomycin Dosing and Monitoring in Elderly Patients
Favorite
4:15 PM - 5:15 PM
(5-013) Mold - Expensive to Miss; Expensive to Treat
Favorite
4:15 PM - 5:15 PM
(5-014) The Purpose of Research: A Look at Objective Statements in Biomedical Sciences Education Journals
Favorite
4:15 PM - 5:15 PM
(5-015) Double Trouble: Evans Syndrome Exacerbated by Tuberculosis in a Pediatric Patient
Favorite
4:15 PM - 5:15 PM
(5-016) Impact of the COVID-19 Pandemic on Displacement in Advanced Pharmacy Practice Experiences
Favorite
4:15 PM - 5:15 PM
(5-017) Outcomes of Alteplase (TPA) and Tenecteplase (TNK) on Door-to-Needle Time
Favorite
4:15 PM - 5:15 PM
(5-018) Medication Use Evaluation of Remdesivir for COVID-19 Treatment in Pediatric Hematology and Oncology Patients
Favorite
4:15 PM - 5:15 PM
(5-019) What Constitutes "Extremely Elevated"? A Case Report Examining High Anion Gap Metabolic Acidosis
Favorite
4:15 PM - 5:15 PM
(5-020) Not Your Average Escherichia: The Curious Case of Escherichia albertii
Favorite
4:15 PM - 5:15 PM
(5-021) Evaluation of Enoxaparin Dosing and Target Attainment in Pediatric Cardiology and Cardiac Intensive Care Patients
Favorite
4:15 PM - 5:15 PM
(5-022) Evaluation of Antibiotic Prophylaxis in Open Bone Fractures at a Large Academic Medical Center
Favorite
4:15 PM - 5:15 PM
(5-023) Evaluation of Hepatitis C Management in Liver Transplant Recipients of Hepatitis C Virus-Positive Allografts
Favorite
4:15 PM - 5:15 PM
(5-024) Evaluation of Inhaler Prescribing at Discharge Following Hospitalization for Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Favorite
4:15 PM - 5:15 PM
(5-025) Pilot Program for Student-Led Stroke Medication Reconciliation in an Acute Care Rehabilitation Hospital
Favorite
4:15 PM - 5:15 PM
(5-026) Think of a “collateral damage”: Understanding Negative Impact of Ceftriaxone vs. Cefazolin at a Community Teaching Hospital.
Favorite
4:15 PM - 5:15 PM
(5-027) GPA Calculated from Individually Earned Components of Integrated Pharmacotherapy Coursework as a Predictor of Future Success in a PharmD Curriculum
Favorite
4:15 PM - 5:15 PM
(5-028) Quality Improvement Assessment of Combination Therapy for Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia: Evaluating Treatment Selection and Duration
Favorite
4:15 PM - 5:15 PM
(5-029) Investigation of the Impact of Vancomycin in Patients with Blood Culture Contaminants
Favorite
4:15 PM - 5:15 PM
(5-030) Retrospective Chart Review Assessing Time to First Bowel Movement in Medical Intensive Care Unit Patients Pre and Post Implementation of an ICU Bowel Regimen Protocol
Favorite
4:15 PM - 5:15 PM
(5-031) Clozapine-induced Eosinopenia in Patients with Treatment-resistant Schizophrenia: Case Series and Literature Review
Favorite
4:15 PM - 5:15 PM
(5-032) Human Papillomavirus Vaccine Series Completion Rates After Dose Administration at Community-Based Health Clinics in the Greater Kansas City Area
Favorite
4:15 PM - 5:15 PM
(5-033) Rifaximin Hepatic Encephalopathy Readmission Rate Improvements
Favorite
4:15 PM - 5:15 PM
(5-034) Post-Implementation Outcomes of Meropenem Restriction: A Medication Use Evaluation at a Large Academic Medical Center
Favorite
4:15 PM - 5:15 PM
(5-035) Fixed Dose Rasburicase for the Treatment and Prevention of Hyperuricemia associated with Malignancy: A Medication Use Evaluation
Favorite
4:15 PM - 5:15 PM
(5-036) Integration of Lean Practices in Conducting a Pediatric Clinical Trial
Favorite
4:15 PM - 5:15 PM
(5-037) Evaluation of Order-Specific Weight Belatacept Dosing in Renal Transplant Recipients - Retrospective Analysis of Dose Accuracy Following Therapy Plan Revision
Favorite
4:15 PM - 5:15 PM
(5-038) Systematic Review of Multi-Dose Long-Acting Lipoglycopeptides Compared to Standard-of-Care for the Treatment of Complicated Gram-Positive Infections
Favorite
4:15 PM - 5:15 PM
(5-039) Reappraisal of Safety Monitoring for Patients Receiving Daptomycin
Favorite
4:15 PM - 5:15 PM
(5-040) Barriers and Facilitators of Community Health Workers and Pharmacists Involved in Missouri Pharmacy Vaccine Gap Closure Program
Favorite
4:15 PM - 5:15 PM
(5-041) Evaluation of High Dose Vasopressin in Septic Shock
Favorite
4:15 PM - 5:15 PM
(5-042) Assessing the Projected Impact of National Declines in Pharmacy School Applicants, Graduates, and North American Pharmacists Licensure Examination Pass Rates on the Future Workforce
Favorite
4:15 PM - 5:15 PM
(5-043) Medication Use Evaluation of Remdesivir at an Academic Medical Center
Favorite
4:15 PM - 5:15 PM
(5-044) Evaluation of Fluoroquinolone Use Criteria Across a Multi-Hospital Health System
Favorite
4:15 PM - 5:15 PM
(5-045) Impact of Administration of Intravenous Fluids on Hospital Readmissions Following Bariatric Surgery
Favorite
4:15 PM - 5:15 PM
(5-046) Medication Use Evaluation of Inpatient Dalbavancin Use at an Academic Medical Center
Favorite
4:15 PM - 5:15 PM
(5-047) Assessing Pharmacy Staff Knowledge, Attitudes, and Practices Related to Seasonal Climate-Related Health Hazards
Favorite
4:15 PM - 5:15 PM
(5-048) Evaluating Current Practice of Cangrelor in the Perioperative Setting
Favorite
4:15 PM - 5:15 PM
(5-049) Review of Fixed vs Weight-Based Dosing of Prothrombin Complex Concentrate [Human] in Patients Requiring Emergent Anticoagulation Reversal
Favorite
4:15 PM - 5:15 PM
(5-050) Establishing the Foundation for an Inpatient Pharmacy Operations Dashboard
Favorite
4:15 PM - 5:15 PM
(5-051) Evaluation of Dalbavancin as Outpatient Therapy at a Community Hospital in Butte, Montana
Favorite
4:15 PM - 5:15 PM
(5-052) Evaluation of the Vancomycin Monitoring Protocol of Obese Adults in an Inpatient Setting
Favorite
4:15 PM - 5:15 PM
(5-053) Evaluation of Urinary Tract Infection Therapy for Antimicrobial Stewardship at Community Medical Center in Missoula, Montana
Favorite
4:15 PM - 5:15 PM
(5-054) Impact of Pharmacist Care on COPD Readmission Rates in Veterans in a Rural Health Care System
Favorite
4:15 PM - 5:15 PM
(5-055) Evaluation of Medications Dispensed and Conditions Treated in Rural Communities During an International APPE in the Dominican Republic
Favorite
4:15 PM - 5:15 PM
(5-056) Acute Liver Failure Secondary to Sulfamethoxazole-Induced Liver Injury: A Case Report
Favorite
4:15 PM - 5:15 PM
(5-057) Empowering College Communities: Naloxone Training for Opioid Overdose Prevention
Favorite
4:15 PM - 5:15 PM
(5-058) Experiences and Perspectives of Nebraska Pharmacy Technicians Regarding Social Determinants of Health
Favorite
4:15 PM - 5:15 PM
(5-059) A Survey of Pharmacists Providing Ambulatory Care Pharmacy Services in Nebraska
Favorite
4:15 PM - 5:15 PM
(5-060) Opioid Withdrawal Secondary to Prolonged Use of "Gas Station Heroin"
Favorite
4:15 PM - 5:15 PM
(5-061) Trends in the Usage of Dexamethasone in Suspected Meningitis at Nebraska Medicine
Favorite
4:15 PM - 5:15 PM
(5-062) Intravenous to Oral Antibiotic Therapy (OAT) for Definitive Treatment of Uncomplicated Gram-Negative Rod Bloodstream Infections in Hospitalized Adults
Favorite
4:15 PM - 5:15 PM
(5-063) Evaluation of Bromocriptine for the Treatment of Peripartum Cardiomyopathy
Favorite
4:15 PM - 5:15 PM
(5-064) Utilizing Caenorhabditis Elegans as an Experimental Model to Predict the Effects of Brilaroxazine Compared to Established Antipsychotics
Favorite
4:15 PM - 5:15 PM
(5-065) Takotsubo Cardiomyopathy: A Case of the Broken Heart
Favorite
4:15 PM - 5:15 PM
(5-066) Meeting Community Needs with the CVS Health Spanish Pathway Program
Favorite
4:15 PM - 5:15 PM
(5-067) Evaluating G Protein Coupled Receptor Kinase 4 Family Mutations in Stomach Cancer - Types and Clinical Significance
Favorite
4:15 PM - 5:15 PM
(5-068) Identifying Mutations of Members of the GRK2- like Family in Skin Cancer- Mutations and Potential Clinical Significance
Favorite
4:15 PM - 5:15 PM
(5-069) Detection and Relative Quantitation of mRNA of Tissue Matrix Metalloproteases (MMPs) after Exposure to Doxorubicin in In Vitro Cell Cultures
Favorite
4:15 PM - 5:15 PM
(5-070) Exploring the Effects of G Protein Coupled Receptor Kinase 2 and Beta Arrestin 2 on the Effectiveness of the TAC Regimen- Recovery and Colony Formation
Favorite
4:15 PM - 5:15 PM
(5-071) Exploring the Effects of G Protein Coupled Receptor Kinase 2 and Beta Arrestin 2 on the TAC Regimen- Cancer Cell Adhesion and Spreading
Favorite
4:15 PM - 5:15 PM
(5-072) Exploring The Function Of Dexrazoxane On Doxorubicin Mediated Cardiotoxicity In Primary Human Cardiomyocytes
Favorite
4:15 PM - 5:15 PM
(5-073) New Frontiers in the Treatment of Glioblastoma
Favorite
4:15 PM - 5:15 PM
(5-074) Exploring the Influence of Atypical and Typical Antipsychotics Using Caenorhabditis elegans as an Experimental Model
Favorite
4:15 PM - 5:15 PM
(5-075) Detection and Relative Quantitation of mRNA of Tissue Inhibitors of Matrix Metalloproteases (TIMPs) after Exposure to Doxorubicin in In Vitro Cell Cultures
Favorite
4:15 PM - 5:15 PM
(5-076) Comparing Octopamine and Norepinephrine Activity Using Caenorhabditis Elegans as an Experimental Model
Favorite
4:15 PM - 5:15 PM
(5-077) Detection and Relative Quantitation of Changes in Gene Expression of HIPPO Pathway Proteins in Doxorubicin-Exposed Human Cells by RT-qPCR
Favorite
4:15 PM - 5:15 PM
(5-078) Benchmarking the Evolutionary Trends in Rheumatoid Arthritis Rating Scales
Favorite
4:15 PM - 5:15 PM
(5-079) Evaluation of Titration Practices at a Community Hospital
Favorite
4:15 PM - 5:15 PM
(5-081) Evaluation of Reported Hypersensitivity Reaction to Penicillin in Pregnant Mothers Treated for Group B Streptococcus.
Favorite
4:15 PM - 5:15 PM
(5-082) A Global 5-Year Literature Review of Hypothyroidism Incidence in Breast Cancer Patients Treated With PD-1 Inhibitors: Pembrolizumab or Nivolumab
Favorite
4:15 PM - 5:15 PM
(5-083) Bridging the Divide: Identifying Communication Gaps Between Breast Cancer Patients and Healthcare Providers
Favorite
4:15 PM - 5:15 PM
(5-084) Evaluating Pembrolizumab Biosimilars in the Pipeline: A Comparison of Clinical Trial Designs
Favorite
4:15 PM - 5:15 PM
(5-085) Exploring the Therapeutic Potential of Fecal Microbiota Transplants in Treating Patients with Anti-PD-1 Refractory Metastatic Melanoma
Favorite
4:15 PM - 5:15 PM
(5-086) Safety and Efficacy of Vitamin K in Pediatric Patients
Favorite
4:15 PM - 5:15 PM
(5-087) Examining Pharmacists’ Prescriptive Authority: Assessing Implementation and Impact on Patient Outcomes Around the Globe
Favorite
4:15 PM - 5:15 PM
(5-088) Evaluating Cognitive Decline in Early Alzheimer's Disease Using Donanemab
Favorite
4:15 PM - 5:15 PM
(5-089) Review of Past, Present, and Future Trends of the Treatment of Dementia-related Psychosis
Favorite
4:15 PM - 5:15 PM
(5-090) Trend analysis of outcome measures for oral antipsychotic trials in Schizophrenia: Implications for formulary placement
Favorite
4:15 PM - 5:15 PM
(5-091) Alcohol Usage Trends Before, During, And After Covid-19: Literature Review
Favorite
4:15 PM - 5:15 PM
(5-092) Investigating the Mechanisms by which SARS-CoV-2 Manifests an Autoimmune-like Phenomena to Rationalize the Implication of Immunomodulators in Infected Patients Receiving Supplemental Oxygen or Ventilatory Support
Favorite
4:15 PM - 5:15 PM
(5-093) Clinical Outcomes and Cost Data of IVIG Weight-Based Dosing Strategies for Immune Thrombocytopenia: A Retrospective Analysis
Favorite
4:15 PM - 5:15 PM
(5-094) Metformin-Induced Vitamin B12 Deficiency and its Role in Diabetic Neuropathy: A Comprehensive Review
Favorite
4:15 PM - 5:15 PM
(5-095) Measuring the Perceptions of Psychiatric Care and Recovery amongst Formerly Incarcerated Individuals
Favorite
4:15 PM - 5:15 PM
(5-096) A Review of Evidence Behind the Safety and Efficacy of Sunscreen Agents
Favorite
4:15 PM - 5:15 PM
(5-097) Effects of Implementing a Pneumonia Care Bundle on Hospital Mortality Rates Utilizing Pneumonia Severity Scoring: A Retrospective, Multi-Center Analysis
Favorite
4:15 PM - 5:15 PM
(5-098) Pandemic Pressures: A Decline in Psychological Well-Being Among Higher Education Students During the Coronavirus Pandemic
Favorite
4:15 PM - 5:15 PM
(5-099) Caffeine Usage, Withdrawal, and Implications in an Intensive Care Unit (ICU) and Perioperative Setting
Favorite
4:15 PM - 5:15 PM
(5-100) Evaluation of Safety and Efficacy of Novel FDA-Approved CRISPR/Cas9 Therapies, Exagamglogene Autotemcel and Betibeglogene Autotemcel, for Beta Thalassemia: A Literature Review
Favorite
4:15 PM - 5:15 PM
(5-101) Restoration of the Antibiotic-Impacted Microbiome in Human Infants and Children: A Case Study
Favorite
4:15 PM - 5:15 PM
(5-102) Gender and Medical Comorbidity Differences in 30 Day Readmission Rates of Bipolar Disorder Patients
Favorite
4:15 PM - 5:15 PM
(5-103) Evaluation of Enhancing Safe Fentanyl Patch Assessment and Administration in an Acute Care Community Hospital
Favorite
4:15 PM - 5:15 PM
(5-104) Comprehensive review of utilizing resistin as a biomarker to insulin resistance in Type 2 Diabetes Mellitus
Favorite
4:15 PM - 5:15 PM
(5-106) Identifying Sexually Transmitted Infections (STIs): The Added Value of Extragenital Gonorrhea and Chlamydia Testing Beyond Urogenital Screening in Sexual Minority Men (SMM) with HIV
Favorite
4:15 PM - 5:15 PM
(5-107) Evaluation of readability of educational materials for coronary artery disease and the impact of health literacy and behavioral psychology on medication adherence and health outcomes.
Favorite
4:15 PM - 5:15 PM
(5-108) Examining an Emerging Global Threat and its Implications: A Historical Perspective on Ceftriaxone Resistance in Gonorrhea
Favorite
4:15 PM - 5:15 PM
(5-109) Renoprotective Effects of Sodium-Glucose Cotransporter 2 Inhibitors Against Vancomycin-Induced Acute Kidney Injury
Favorite
4:15 PM - 5:15 PM
(5-110) Psilocybin Therapy in End-of-Life Care: A Literature Review on Addressing Psychological and Existential Distress in Terminally Ill Patients
Favorite
4:15 PM - 5:15 PM
(5-111) Analysis of Immunotherapeutic Mechanisms in Phase II and III Metastatic Colorectal Cancer Clinical Trials
Favorite
4:15 PM - 5:15 PM
(5-112) Evaluating Sugammadex Usage and Dosing in Postoperative Neuromuscular Blockade Reversal
Favorite
4:15 PM - 5:15 PM
(5-113) Survey to Evaluate the Quality of the Mentorship Program Amongst Faculty Members at a School of Pharmacy
Favorite
4:15 PM - 5:15 PM
(5-114) Evaluating the Impact of Deep Brain Stimulation on Tremor Reduction and Quality of Life in Parkinson’s Disease Adult Patients: A Literature Review
Favorite
4:15 PM - 5:15 PM
(5-115) Assessing the Use of Augmented Reality and Virtual Reality in Managing Symptoms of Alzheimer’s Disease and Dementia: A Literature Review
Favorite
4:15 PM - 5:15 PM
(5-117) Retrospective Evaluation of the Management of Febrile Neutropenia in Patients at a Community Hospital
Favorite
4:15 PM - 5:15 PM
(5-118) Characterizing the Presence and Treatment of Urinary Tract Infections in Older Adults
Favorite
4:15 PM - 5:15 PM
(5-119) How Prescribing Trends Have Influenced Availability of Brand Semaglutide, The Danger of Counterfeit Compounding, and The Impact of Pharmacist Interventions
Favorite
4:15 PM - 5:15 PM
(5-120) Initial Evaluation of Vancomycin Prescribing Practices at a Community Hospital: Assessing the Needs for a Dosing Nomogram
Favorite
4:15 PM - 5:15 PM
(5-121) Analysis of a High-Dose Buprenorphine Induction Protocol for the Treatment of Opioid Use Disorder in the Emergency Department
Favorite
4:15 PM - 5:15 PM
(5-122) Case Report: Calcium Channel Blocker Mixed Overdose
Favorite
4:15 PM - 5:15 PM
(5-123) Molecular Dynamics Simulations to Understand Resistance to ALK Tyrosine Kinase Inhibitor Alectinib
Favorite
4:15 PM - 5:15 PM
(5-124) SGLT2 Inhibitors in Post-Myocardial Infarction to Prevent the Onset of Congestive Heart Failure Regardless of Diabetic Status
Favorite
4:15 PM - 5:15 PM
(5-125) Landscape Analysis of Patient Support Programs for GLP-1 Medications in Diabetes and Weight Loss
Favorite
4:15 PM - 5:15 PM
(5-126) Impact of Proton Pump Inhibitor (PPI) use on the risk and recurrence of Clostridium difficile Infection (CDI)
Favorite
4:15 PM - 5:15 PM
(5-127) Evaluation of the Use of Droperidol: A Single-Center Retrospective Analysis
Favorite
4:15 PM - 5:15 PM
(5-128) Time to Therapeutic Range Amongst Patients Receiving Heparin Infusions in the Emergency Department
Favorite
4:15 PM - 5:15 PM
(5-129) Clinical and Economic Impact of Personalized Genomic Testing in Oncology
Favorite
4:15 PM - 5:15 PM
(5-130) National Comprehensive Cancer Network (NCCN) Guidelines: Identifying Gaps, Trends, and Opportunities in Targeted and Immune Therapies Across Major Cancer Types
Favorite
4:15 PM - 5:15 PM
(5-131) Navigating Regulatory Challenges in Oncology Drug Development: A Literature Review
Favorite
4:15 PM - 5:15 PM
(5-132) Developing and Assessing an Interprofessional Pharmacy Student Peer-Led Curriculum for Pre-Pharmacy College Students
Favorite
4:15 PM - 5:15 PM
(5-133) Advancements In Adjuvant Therapy For Clear Cell Renal Cell Carcinoma: a Comprehensive Review Of Trials Conducted Within the Past Ten Years and Novel Therapeutic Mechanisms
Favorite
4:15 PM - 5:15 PM
(5-134) Evaluation of Clinical Outcomes in Uninsured Population with Diabetes at a Large Health System Utilizing a Free Medication Program
Favorite
4:15 PM - 5:15 PM
(5-135) Comparative Evaluation of Loading and Not Loading Clopidogrel in Patients with Minor Stroke or Transient Ischemic Attacks
Favorite
4:15 PM - 5:15 PM
(5-136) Evaluating the appropriate use of hydralazine in a community teaching hospital: A retrospective analysis
Favorite
4:15 PM - 5:15 PM
(5-137) Evaluation of Statin Intensity in Endovascular Abdominal Aortic Aneurysm Repair: A Retrospective Analysis
Favorite
4:15 PM - 5:15 PM
(5-138) Literature Review of the Impact of Health Literacy on Type 2 Diabetes Mellitus
Favorite
4:15 PM - 5:15 PM
(5-139) Atopic Dermatitis Clinical Trials: Trends and Analysis of Outcome Endpoints
Favorite
4:15 PM - 5:15 PM
(5-140) Ceftriaxone Utilization for Community Acquired Pneumonia
Favorite
4:15 PM - 5:15 PM
(5-141) Evaluating the Pharmacological Efficacy of Evidence-Based Treatments for Steroid Refractory Acute GVHD
Favorite
4:15 PM - 5:15 PM
(5-142) Sodium Zirconium Cyclosilicate Use in the Management of Patients with Hyperkalemia
Favorite
4:15 PM - 5:15 PM
(5-143) Insulin Infusion Safety and Monitoring in the Emergency Department
Favorite
4:15 PM - 5:15 PM
(5-144) Review of Management of Hemophagocytic Lymphohistiocytosis-like Syndrome Following Chimeric Antigen Receptor T-cell Therapy: Diagnosis, Treatment, and Differentiation from Cytokine Release Syndrome
Favorite
4:15 PM - 5:15 PM
(5-145) Review of Quality of Life Measurement Prevalence in CAR-T Therapy Clinical Trials: Assessing and Addressing Challenges
Favorite
4:15 PM - 5:15 PM
(5-146) Abortive Treatments for Acute Migraine: A Narrative Review of Lasmiditan and the Calcitonin Gene-Receptor Peptide (CGRP) Receptor Antagonists
Favorite
4:15 PM - 5:15 PM
(5-147) Association of Serum Lithium and Valproic Acid Levels with Bipolar Disorder Readmission Rates
Favorite
4:15 PM - 5:15 PM
(5-148) Targeting Thrombosis: A Review of the Phase II and III Clinical Trial Findings for the Novel Factor XI and XIa Inhibitors
Favorite
4:15 PM - 5:15 PM
(5-149) Evaluating Patient Assistance Programs: Trends and Gaps Among Top 20 Selling Drugs in 2023
Favorite
4:15 PM - 5:15 PM
(5-150) Racial and Ethnic Disparities found in Phase II and Phase III Clinical Trials of Multiple Sclerosis Therapy
Favorite
4:15 PM - 5:15 PM
(5-151) GLP-1 Receptor Agonists’ Effects on Fertility: A Descriptive Analysis
Favorite
4:15 PM - 5:15 PM
(5-152) Evaluation of the Use of Artificial Intelligence Across Functional Areas in the Pharmaceutical Industry
Favorite
4:15 PM - 5:15 PM
(5-153) Impact of Cannabinoids for the Management of Chemo-induced Nausea and Vomiting in Oncology Patients: A Literature Review
Favorite
4:15 PM - 5:15 PM
(5-154) Trends of Gene Therapy Treatment for Hemophilia A and the Impact in Rare Disease Therapy for the Pharmaceutical Industry: A Literature Review
Favorite
4:15 PM - 5:15 PM
(5-155) Update on the Management of Plaque Psoriasis in Children and Adolescents
Favorite
4:15 PM - 5:15 PM
(5-156) Risk-Benefit Analysis on the use of Complex Innovative Trial Design in Clinical Studies
Favorite
4:15 PM - 5:15 PM
(5-157) Evaluation of Weight-Based Diltiazem Boluses on Critical Care Admissions for Patients with Atrial Fibrillation with Rapid Ventricular Response
Favorite
4:15 PM - 5:15 PM
(5-158) A retrospective analysis of gastrointestinal prophylaxis appropriateness in a general medicine population at a community hospital
Favorite
4:15 PM - 5:15 PM
(5-159) Trends in Inclusion of Patients Living with HIV in Phase 2 and Phase 3 Non Hodgkin's Lymphoma Clinical Trials
Favorite
4:15 PM - 5:15 PM
(5-160) Accelerating Hope: A 10-Year Benchmarking Review of the United States Food and Drug Administration Accelerated Approvals in Metastatic Non-Small Cell Lung Cancer
Favorite
4:15 PM - 5:15 PM
(5-161) Summary of Standard and Relapsed/Refractory Treatment Options for Neuroblastoma
Favorite
4:15 PM - 5:15 PM
(5-162) Investigating Mitigation Strategies for Obstacles Faced by Pediatric Populations in Regards to Recruitment and Retention in Clinical Trials from a Clinical Operations Lens
Favorite
4:15 PM - 5:15 PM
(5-163) What effect does the introduction of a unit-based infectious disease guideline have on outcomes in neonates?
Favorite
4:15 PM - 5:15 PM
(5-164) Breaking Barriers: Reviewing a Decade of Diversity in Schizophrenia Clinical Trials for Novel Drugs in the United States
Favorite
4:15 PM - 5:15 PM
(5-165) Use of Caffeine Sodium Benzoate for Headaches in Adults
Favorite
4:15 PM - 5:15 PM
(5-166) Impact of Comorbid Conditions on 30-Day Readmission Rates in Hospitalized Pneumonia Patients: A Retrospective Study
Favorite
4:15 PM - 5:15 PM
(5-167) Patient Reported Outcomes and Quality of Life Metrics utilized by Melanoma Treatments: Implications for Marketing
Favorite
4:15 PM - 5:15 PM
(5-168) Advancing Alzheimer's Disease Detection: A Literature Review of Novel Plasma, Saliva, and Ocular Diagnostic Tools and Biomarkers
Favorite
4:15 PM - 5:15 PM
(5-169) Appropriateness of Pharmacologic Sedation for the Duration of Paralysis during Rapid Sequence Intubation in the Emergency Department and Intensive Care Unit
Favorite
4:15 PM - 5:15 PM
(5-170) Retrospective Evaluation of Droperidol Use in the Emergency Department
Favorite
4:15 PM - 5:15 PM
(5-171) Simulation-Based Learning for Cardiac Arrest in an Outpatient Pharmacy Setting
Favorite
4:15 PM - 5:15 PM
(5-172) Comparing the Efficacy of Ceftriaxone 1 Gram Versus 2 Gram Dosing in Various Bacterial Infections
Favorite
4:15 PM - 5:15 PM
(5-173) Evaluation of ChatGPT's accuracy and completeness in answering drug information questions compared to official prescribing information.
Favorite
4:15 PM - 5:15 PM
(5-174) Evaluating Premedications Administered in Patients Receiving Taxane Therapy and Analyze Infusion Related Reactions
Favorite
4:15 PM - 5:15 PM
(5-175) Assessing the Availability of Patient Assistance Programs for the Pediatric Population Across Common Drug Classes
Favorite
4:15 PM - 5:15 PM
(5-176) From animal sedative to “skin eating” street drug: a literature review analyzing illicit drug trends to predict the potential trajectory of xylazine
Favorite
4:15 PM - 5:15 PM
(5-177) A Review of Etranacogene Dezaparvovec and Fidanacogene Elaparvovec for the Treatment of Hemophilia B
Favorite
4:15 PM - 5:15 PM
(5-178) Evolving Place in Therapy: Examining the Increased Risk of Cytomegalovirus Incidence with Belatacept Post-Calcineurin Inhibitor Conversion in Recipients of Kidney Transplantation
Favorite
4:15 PM - 5:15 PM
(5-179) Protein Marker Changes as a Result of Glutamatergic Signaling & Immune Checkpoint Inhibition in Melanoma-Prone Transgenic Mice
Favorite
4:15 PM - 5:15 PM
(5-180) Evaluation of the Safety of Empagliflozin compared to Lisinopril Initiation in an In-patient Post-Cardiothoracic Surgery Patient Population
Favorite
4:15 PM - 5:15 PM
(5-181) Clinical Trial Diversity in Colorectal Cancer, A Literature Review of Studies Representing American Indian/ Alaska Native Patients in the US
Favorite
4:15 PM - 5:15 PM
(5-182) Looking Beyond Detection: Evaluating Value and Providing Recommendations to Enhance Patient Access to Multi Cancer Detection Tests for Equitable Care
Favorite
4:15 PM - 5:15 PM
(5-183) Characterization and Evaluation of Sugammadex Use in the Emergency Department
Favorite
4:15 PM - 5:15 PM
(5-184) The Evolution of Mycophenolate Mofetil (MMF): A 30-Year Journey in Clinical Practice
Favorite
4:15 PM - 5:15 PM
(5-185) Cracking the Code: Key Factors Driving ART Adherence in Young Adults with HIV
Favorite
4:15 PM - 5:15 PM
(5-186) Cetirizine medication use evaluation for prophylaxis of hypersensitivity infusion reactions.
Favorite
4:15 PM - 5:15 PM
(5-187) Dofetilide-Induced Torsade de Pointes
Favorite
4:15 PM - 5:15 PM
(5-188) Evaluation of Antibiotic Prescribing Patterns at Discharge for Community-Acquired Pneumonia (CAP) – A Retrospective Study
Favorite
4:15 PM - 5:15 PM
(5-189) Recombinant Adjuvanted Hepatitis B Vaccination in People With Human Immunodeficiency Virus
Favorite
4:15 PM - 5:15 PM
(5-190) Retrospective Review of Doxycycline Post-Exposure Prophylaxis
Favorite
4:15 PM - 5:15 PM
(5-191) Bioaccumulation of Microplastics in Decedent Tissues: Quantification by Pyrolysis-Gas Chromatography/Mass Spectrometry
Favorite
4:15 PM - 5:15 PM
(5-192) Low-Dose Buprenorphine Induction in Obstetric Patients; Retrospective Analysis of a Protocol Implementation
Favorite
4:15 PM - 5:15 PM
(5-194) Content analysis of patient-facing educational materials on medication use in dialysis
Favorite
4:15 PM - 5:15 PM
(5-195) Validation of the Medication Regimen Complexity Index in the Weight Management Ambulatory Care Setting
Favorite
4:15 PM - 5:15 PM
(5-196) Environmental Scan of Anticoagulation-Related Oversight for Atrial Fibrillation in Five English-Speaking Countries
Favorite
4:15 PM - 5:15 PM
(5-197) Retrospective Evaluation of Provoked Left Ventricular Outflow Tract Gradient with Mavacamten Using Real-World Data from a Private Cardiology Practice Utilizing Pharmacist Monitoring
Favorite
4:15 PM - 5:15 PM
(5-198) Impact of a Clinical Pharmacy Team on Physician Satisfaction in a Private Cardiology Clinic
Favorite
4:15 PM - 5:15 PM
(5-199) Consequence of Vancomycin-Associated Acute Kidney Injury among Adult Hospitalized Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream infections
Favorite
4:15 PM - 5:15 PM
(5-200) Effect of Reported Antibiotic Allergies on Perioperative Prophylactic Antibiotics and Outcomes
Favorite
4:15 PM - 5:15 PM
(5-201) Impact of the Combination of Linezolid plus Piperacillin-Tazobactam on Incidence of Thrombocytopenia
Favorite
4:15 PM - 5:15 PM
(5-202) Choice of Antifungal Prophylaxis and Risk of Invasive Fungal Disease for Patients with Acute Leukemia on Oral Anticancer Therapies with Significant CYP450 Drug Interactions
Favorite
4:15 PM - 5:15 PM
(5-203) Complication of pharmacokinetic and pharmacodynamic parameters of currently approved oncologic immunotherapy
Favorite
4:15 PM - 5:15 PM
(5-204) Implementing Hard Stop Alerts in Hospital Software: Reducing Inappropriate Continuation of Oral Oncolytic Prescriptions Through Enhanced Safety Mechanisms
Favorite
4:15 PM - 5:15 PM
(5-206) ACPHS Alumni Path to Industry
Favorite
4:15 PM - 5:15 PM
(5-207) Evaluation of Mycelium Extracts and their Immunological Effects in Cancer Therapies
Favorite
4:15 PM - 5:15 PM
(5-208) Long-term Efficacy Profile of Zuranolone in Postpartum Depression Compared to Selective Serotonin Reuptake Inhibitors: A Literature Review
Favorite
4:15 PM - 5:15 PM
(5-209) Natural Products That May Be Beneficial for Reducing Blood Pressure
Favorite
4:15 PM - 5:15 PM
(5-210) Investigating the Neuroprotective Effects of Flavonoids on Oxidative Stress, Tau Pathology, and Beta Amyloid Aggregation in Alzheimer’s Disease: A Systematic Literature Review
Favorite
4:15 PM - 5:15 PM
(5-211) Optimizing Intravenous Drug Concentrations in Neonatal and Pediatric Intensive Care Unit Smart Infusion Pump Libraries
Favorite
4:15 PM - 5:15 PM
(5-212) Evaluation of a Shadowing Program on Student Confidence in Understanding the Role of an Ambulatory Care Clinical Pharmacist
Favorite
4:15 PM - 5:15 PM
(5-213) Assessment of Cytotoxicity and Synergy of Combination Chemotherapy Regimens in Pediatric ALL and AML Cell Lines
Favorite
4:15 PM - 5:15 PM
(5-214) US Schools of Pharmacy PGY1 Pharmacy Residency Preparation Strategies Associated with Higher Student Match Rate Success
Favorite
4:15 PM - 5:15 PM
(5-215) Availability of Pharmacist-Dispensed Hormonal Contraceptives in New York State 6 Months Post-Implementation
Favorite
4:15 PM - 5:15 PM
(5-216) Evaluating the Patient Outcomes of a Modified Methadone Induction Schedule
Favorite
4:15 PM - 5:15 PM
(5-217) Repurposing clinical-stage therapeutic antibodies for antibody-drug conjugate applications
Favorite
4:15 PM - 5:15 PM
(5-218) Impact of a Geriatric Medication Safety Initiative, Pharmacist-Driven Procedure, on Opiate Utilization in a Transitional Care Unit
Favorite
4:15 PM - 5:15 PM
(5-219) Covalent Chemical Probes Reveal Mycobacterial Prokaryotic Ubiquitin Proteasome System PafA Ligandable Sites for Drug Discovery
Favorite
4:15 PM - 5:15 PM
(5-220) Evaluation of Asymptomatic Bacteriuria Management Among Renal Transplant Patients
Favorite
4:15 PM - 5:15 PM
(5-221) Evaluation of Extended Antibiotic Prophylaxis for Primary Arthroplasty
Favorite
4:15 PM - 5:15 PM
(5-222) Reported Cases of Therapeutic Failure with HIV Long Acting Injectable
Favorite
4:15 PM - 5:15 PM
(5-223) Investigating the Role of Type 1 Interferon in Capillary Damage: Implications for Myositis
Favorite
4:15 PM - 5:15 PM
(5-224) Analyzing the Prevalence of Cannabis Use and Drug-Drug Interactions Within the Stony Brook University 911 World Trade Center Health and Wellness Clinic Patient Population
Favorite
4:15 PM - 5:15 PM
(5-225) Examining the Association Between Glucagon-Like Peptide-1 Receptor Agonists and Suicidality: An Analysis of Medication Expenditure Panel Survey Data 2018-2021
Favorite
4:15 PM - 5:15 PM
(5-226) Second Generation Antipsychotic-Associated Serious Adverse Events in Women
Favorite
4:15 PM - 5:15 PM
(5-227) Identifying Preventable Factors and Targeted Interventions: A Retrospective Root Cause Analysis of COPD Readmissions at Bronx Safety-Net Hospitals
Favorite
4:15 PM - 5:15 PM
(5-228) Pharmacovigilance Study Analyzing Safety and Error Reports of Compounded Glucagon-Like Peptide-1 Receptor Agonists Using a National Adverse Event Database
Favorite
4:15 PM - 5:15 PM
(5-229) The role of MYC modulation in HER2+ breast cancer chemosensitization
Favorite
4:15 PM - 5:15 PM
(5-230) Descriptive Report of the Need for Indication and Weight on Antibiotic Prescriptions for Pediatric Patients in the Community Setting
Favorite
4:15 PM - 5:15 PM
(5-231) Exploring the Effects on the Epithelial to Mesenchymal Transition induced by Sulforaphane as compared to NTP/TPZ in Pancreatic Adenocarcinoma Cells
Favorite
4:15 PM - 5:15 PM
(5-232) Systematic Review of Chasteberry (Vitex agnus-castus) for the Treatment of Menopause Symptoms
Favorite
4:15 PM - 5:15 PM
(5-233) Bridging the Gap in Medication Adherence: Comparing Self-Reported Adherence and Barriers Between Patients Who Utilize Adherence Packaging and Those Who Do Not
Favorite
4:15 PM - 5:15 PM
(5-234) Mixed methods systematic review of pharmacist-administered injectable contraception
Favorite
4:15 PM - 5:15 PM
(5-235) Systematic Review of Topical Capsaicin for Acute Management of Cannabinoid Hyperemesis Syndrome
Favorite
4:15 PM - 5:15 PM
(5-236) Therapeutic Drug Monitoring of Rituximab for Treating Childhood Nephrotic Syndrome: A Scoping Review
Favorite
4:15 PM - 5:15 PM
(5-237) Evaluation of student pharmacists' co-curricular engagement across online and traditional pathways
Favorite
4:15 PM - 5:15 PM
(5-238) Role of Adaptogenic Herbs and Mushrooms in Stress Reduction and Mood Elevation
Favorite
4:15 PM - 5:15 PM
(5-239) Impact of Routine Diversity, Equity, and Inclusion (DEI) Programming on Staff Engagement within a Large Academic Medical Center’s Pharmacy Department: A Six-Month Descriptive Study
Favorite
4:15 PM - 5:15 PM
(5-240) Use of Medicinal Mushrooms in Neurological Activity and Cognitive Function Enhancement
Favorite
4:15 PM - 5:15 PM
(5-241) Clinical Importance of Pharmacogenomics for Codeine Dosing: An Analysis of Codeine Metabolism in Arab Populations
Favorite
4:15 PM - 5:15 PM
(5-242) Unlocking the Wonders of Black Seed: Nature's Miraculous Secrets Revealed
Favorite
4:15 PM - 5:15 PM
(5-243) Potential of Psilocybin in the Treatment of Major Depressive Disorder
Favorite
4:15 PM - 5:15 PM
(5-244) Zuranolone: The First and Only Oral Agent for Postpartum Depression – Raising Awareness for a Breakthrough Treatment Option
Favorite
4:15 PM - 5:15 PM
(5-245) Qsymia: Comparative Clinical Relevance to Phentermine and Wegovy in Obesity Management
Favorite
4:15 PM - 5:15 PM
(5-246) The Impact of the Inflation Reduction Act on Prescription Drug Costs and Pharmaceutical Innovation
Favorite
4:15 PM - 5:15 PM
(5-247) Assessment of a Single Vancomycin Concentration to Predict Area Under the Curve (AUC) Target in a Veterans Affairs Population
Favorite
4:15 PM - 5:15 PM
(5-248) Beating the Odds: Innovative Strategies for Preventing Cardiac Complications with LODOCO
Favorite
4:15 PM - 5:15 PM
(5-249) Breast Cancer Detection Using Convolutional Neural Networks
Favorite
4:15 PM - 5:15 PM
(5-250) Evaluating the Clinical Utility of Glypican-3 in Hepatocellular Carcinoma: Pathologic, Diagnostic, and Therapeutic Insights
Favorite
4:15 PM - 5:15 PM
(5-251) Empowering New York State Pharmacists to Navigate OTC Birth Control and Dispensing Self-Administered Hormonal Contraception
Favorite
4:15 PM - 5:15 PM
(5-252) Unveiling the Hidden Risks Due to Adverse Events of Botox Products: Insights from Data Analyses of Food and Drug Administration Adverse Event Reporting System Database
Favorite
4:15 PM - 5:15 PM
(5-253) Assessing the Cost Implications of Transitioning Tablet Splitting from Nursing to Pharmacy
Favorite
4:15 PM - 5:15 PM
(5-254) Impact of Weekly Omnicell Optimization on the Volume of Patient Specific Medication Dispenses
Favorite
4:15 PM - 5:15 PM
(5-255) Pediatric Chemotherapy Guideline Optimization Initiative: A QI Project
Favorite
4:15 PM - 5:15 PM
(5-256) Achieving LDL-C Goals in Very High-Risk ASCVD Patients: A Retrospective Evaluation of Goal Attainment Across Lipid-Lowering Therapies
Favorite
4:15 PM - 5:15 PM
(5-257) Medication Utilization Evaluation of Subcutaneous Methylnaltrexone for Opioid Induced Constipation in a Quaternary Care Teaching Hospital
Favorite
4:15 PM - 5:15 PM
(5-258) Evaluation of Intravenous Acetaminophen Administration; A Retrospective Study at Bellevue Hospital
Favorite
4:15 PM - 5:15 PM
(5-259) A Feasibility Study Evaluating and Validating Bayesian Therapeutic Drug Monitoring Software for Predicting Phenobarbital Levels in the Critically Ill Population
Favorite
4:15 PM - 5:15 PM
(5-260) Accuracy of Indication Based Prescribing Documentation for Anticoagulants-A Retrospective Review
Favorite
4:15 PM - 5:15 PM
(5-261) Vitamin B9 Supplementation and Its Associations with Cognitive Performance in the General Healthy Population: A Scoping Review
Favorite
4:15 PM - 5:15 PM
(5-262) Crushability Analysis of Immediate-Release Oral Tablets and Capsules Among Novel FDA Approvals in 2023
Favorite
4:15 PM - 5:15 PM
(5-263) Dalbavancin Use at a Health System Network in Compliance with a Standard Plan of Treatment for Infective Endocarditis and Osteomyelitis
Favorite
4:15 PM - 5:15 PM
(5-264) Leading Biologics in Pharmacy Practice: The Role of Pharmacists
Favorite
4:15 PM - 5:15 PM
(5-265) Boosting Breast Cancer Immunotherapy: Microparticulate Approach with Synergistic Adjuvants
Favorite
4:15 PM - 5:15 PM
(5-266) Minimize Waste: Effects of Phenylephrine Concentration Change on Drug Waste in the Operating Rooms
Favorite
4:15 PM - 5:15 PM
(5-267) Assessment of Adult Diabetes Management in Roatan, Honduras: A Multiyear Descriptive Study
Favorite
4:15 PM - 5:15 PM
(5-268) Maximizing Care and Savings in FQHCs: the Synergistic Union of Clinical Practice Pharmacists and the 340B Program
Favorite
4:15 PM - 5:15 PM
(5-269) Impact of Order Set Implementation on Institutional Management of Clostridioides difficile in Adult Patients
Favorite
4:15 PM - 5:15 PM
(5-270) Formulation Development and in vitro Characterization of Regorafenib-Loaded Polymeric Nanoparticles
Favorite
4:15 PM - 5:15 PM
(5-271) Evaluation of Antibiotic Use During a Medical Mission Trip in Guatemala: An Observational Study
Favorite
4:15 PM - 5:15 PM
(5-272) Cost-Benefit Analysis of a Pharmacy Formulary for a Non-Profit Community Health Center
Favorite
4:15 PM - 5:15 PM
(5-273) Tenecteplase Administered in a Patient on Concomitant Tranexamic Acid Therapy
Favorite
4:15 PM - 5:15 PM
(5-275) Exploration of Medication Acquisition for Clinics Serving Underprivileged Patients
Favorite
4:15 PM - 5:15 PM
(5-276) Genetic Trends and Antibiotic Susceptibilities of Multi-drug-resistant Pseudomonas aeruginosa Isolates at Nassau University Medical Center
Favorite
4:15 PM - 5:15 PM
(5-277) Pharmacists’ Perceptions Regarding Immunization Services, Preference for Reimbursement, and Implications for Provider Status in New York.
Favorite
4:15 PM - 5:15 PM
(5-278) Analysis of Student Knowledge and Perceptions of Ambulatory Care Pharmacy
Favorite
4:15 PM - 5:15 PM
(5-279) Evaluation of Proton Pump Inhibitor Prescribing Practices in a Primary Care Clinic
Favorite
4:15 PM - 5:15 PM
(5-280) The use of tobacco, e-cigarette or vaping among college students
Favorite
4:15 PM - 5:15 PM
(5-281) Unraveling the Potential of Glucagon-Like Peptide-1 Agonists in Treating Nonalcoholic Fatty Liver Disease: A Literature Review
Favorite
4:15 PM - 5:15 PM
(5-282) Understanding Pediatric and Adolescent Antibiotic Prescribing Patterns and Challenges in the Community Setting: A Pharmacists' Perspective
Favorite
4:15 PM - 5:15 PM
(5-283) Linezolid-Associated Hyponatremia in Traumatic Brain Injury Patients
Favorite
4:15 PM - 5:15 PM
(5-284) Assessing Effectiveness and Usefulness of Pharmacy Drug Reference Cards for a Global Medical Mission
Favorite
4:15 PM - 5:15 PM
(5-285) Assessing the Prevalence and Rationale of Concurrent Antipsychotic Use in Hospitalized Patients: A Retrospective Medication Use Evaluation
Favorite
4:15 PM - 5:15 PM
(5-286) Evaluation of Body Composition Change in Adults on Glucagon-like Peptide-1 Agonists vs. Glucagon-like Peptide-1/ Glucose-dependent Insulinotropic Polypeptide Agonists
Favorite
4:15 PM - 5:15 PM
(5-287) GLP-1: The Surprising Sidekick in the Battle Against Polycystic Ovary Syndrome (PCOS)
Favorite
4:15 PM - 5:15 PM
(5-288) High-Performance Liquid Chromatographic (HPLC) Analysis of Ropivacaine for Stability Evaluation
Favorite
4:15 PM - 5:15 PM
(5-289) Vancomycin Dosing and Monitoring at Nassau University Medical Center
Favorite
4:15 PM - 5:15 PM
(5-290) Unusual Case of Statin-Induced Rhabdomyolysis: A Comparison Between Toxic Statin Myopathy and Statin-Induced Necrotizing Autoimmune Myopathy
Favorite
4:15 PM - 5:15 PM
(5-291) Assessment of Demographic Trends and Appropriateness of Antibiotic Prescribing Among Patients With Varying Renal Functions
Favorite
4:15 PM - 5:15 PM
(5-292) Evaluation of Methicillin-Resistant Staphylococcus Aureus (MRSA) Nares Screening in Patients Prescribed Intravenous Vancomycin
Favorite
4:15 PM - 5:15 PM
(5-293) Therapeutic Alternatives for African Immigrants Entering the United States with HIV Drug Therapy Resistance
Favorite
4:15 PM - 5:15 PM
(5-295) Pharmacy Student Perspectives on Co-Curricular Engagement: Navigating the Evolving Landscape of Accreditation Standards
Favorite
4:15 PM - 5:15 PM
(5-296) Antifungal Prophylaxis Guideline Compliance in Pediatric Oncology and Stem Cell Transplantation Patients
Favorite
4:15 PM - 5:15 PM
(5-297) Are Novel Buprenorphine Treatments Better than the Traditional Approach? A Comprehensive Review of Economics and Patient Outcomes in Opioid Use Disorder
Favorite
4:15 PM - 5:15 PM
(5-298) Dexamethasone vs methylprednisolone for treatment of critical asthma in pediatric patients in the pediatric intensive care unit: A descriptive literature review of safety and efficacy.
Favorite
4:15 PM - 5:15 PM
(5-299) Soy Protein Isolate Nanoparticles for Improving the Solubility of Poorly Water-Soluble Drugs
Favorite
4:15 PM - 5:15 PM
(5-300) Pharmacy Students’ Engagement and Perspective on Research at St. John’s University College of Pharmacy and Health Sciences
Favorite
4:15 PM - 5:15 PM
(5-301) Bridging the Gap: Analyzing Pharmacy Education and Pharmacist Readiness for Pharma Industry Roles
Favorite
4:15 PM - 5:15 PM
(5-302) Evaluation of Hypoglycemic Events and Opportunities for Improvement at an Academic Medical Center
Favorite
4:15 PM - 5:15 PM
(5-303) Assessing Prescription Delays in Rheumatoid Arthritis Treatment: The Impact of Coverage Policies on Access to Abatacept Versus Adalimumab
Favorite
4:15 PM - 5:15 PM
(5-304) Analysis of Glucagon Like Peptide 1 (GLP-1) Receptor Agonist Misinformation on YouTube
Favorite
4:15 PM - 5:15 PM
(5-305) Evaluating Pharmacist Integration in Emergency Response: Analyzing Emergency Support Function #8 (ESF-8) Protocols in Top U.S. Preparedness States During the COVID-19 Pandemic
Favorite
4:15 PM - 5:15 PM
(5-306) Design and synthesis of SIX1-EYA2 transcriptional complex inhibitors.
Favorite
4:15 PM - 5:15 PM
(5-307) Evaluation of Mineralocorticoid Receptor Antagonists and Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Heart Failure With Preserved Ejection Fraction
Favorite
4:15 PM - 5:15 PM
(5-308) Comparison of Linagliptin to Insulin in the Management of Type 2 Diabetes Mellitus in Hospitalized Patients
Favorite
4:15 PM - 5:15 PM
(5-309) Evaluation of Body Composition in World Trade Center Responders Taking Glucagon-like Peptide-1 and Glucagon-like Peptide-1 / Glucose-dependent Insulinotropic Polypeptide Agonists
Favorite
4:15 PM - 5:15 PM
(5-310) Exposure to Immune Checkpoint Inhibitors Increases Risk of Endocrinopathies
Favorite
4:15 PM - 5:15 PM
(5-311) Use of Letermovir in Allogeneic Transplant Patients at Intermediate Risk for Cytomegalovirus
Favorite
4:15 PM - 5:15 PM
(5-312) Recent Trends in Diagnosis, Treatment and Control of Hypertension among African Americans: The National Health and Nutrition Examination Survey, 2009 to 2020
Favorite
4:15 PM - 5:15 PM
(5-313) Comparing Tolerability and Toxicity of Calaspargase pegol and Pegaspargase in Pediatric Leukemia Patients
Favorite
4:15 PM - 5:15 PM
(5-314) Creating an Enterprise Standardized "Do Not Crush" List for Safe Medication Practices at a Large Health System
Favorite
4:15 PM - 5:15 PM
(5-315) Can I Really Get Antibiotics Online Without Seeing A Prescriber?
Favorite
4:15 PM - 5:15 PM
(5-316) Pharmacist-led Transitions of Care Program Impact on 30-day Heart Failure Readmission Rate
Favorite
4:15 PM - 5:15 PM
(5-317) Characteristics of Patients with Carbapenem-Resistant Pseudomonas aeruginosa Infections at Nassau University Medical Center
Favorite
4:15 PM - 5:15 PM
(5-318) Optimization of Automated Medication Dispensing Systems in Intensive-Care Units and the Emergency Department in a Community Hospital
Favorite
4:15 PM - 5:15 PM
(5-319) Medication adherence among pharmacy students during a simulated community pharmacy practice learning activity
Favorite
4:15 PM - 5:15 PM
(5-320) Enhancement of Vincristine Efficacy in Leukemia and Lymphoma by Cannabidiol
Favorite
4:15 PM - 5:15 PM
(5-321) Impact of pharmacist-driven continuous glucose monitoring in ambulatory care pharmacy practice
Favorite
4:15 PM - 5:15 PM
(5-322) Utility of transitioning from propofol to dexmedetomidine in preparation for extubation in mechanically ventilated patients in the intensive care unit
Favorite
4:15 PM - 5:15 PM
(5-323) Role of Gut Microbiota in Chemotherapy, Immunotherapy, and Host Therapeutic Responses
Favorite
4:15 PM - 5:15 PM
(5-324) Systematic Review: Efficacy and Safety of Intravenous Diltiazem vs. Metoprolol in Atrial Fibrillation with Rapid Ventricular Response (AFRVR)
Favorite
4:15 PM - 5:15 PM
(5-325) Utilization of Chromogenic Factor X Assays for Warfarin Monitoring in Antiphospholipid Syndrome
Favorite
4:15 PM - 5:15 PM
(5-326) Avycaz and Zerbaxa Use in a New York City Public Hospital
Favorite
4:15 PM - 5:15 PM
(5-327) Effectiveness of Botulinum Toxin A for Plantar and Lumbar Fasciitis: A Meta-Analysis of Randomized Controlled Trials
Favorite
4:15 PM - 5:15 PM
(5-328) Breaking Barriers: The Evolution of Resistance in Novel Antiretrovirals for The Treatment of Human Immunodeficiency Virus
Favorite
4:15 PM - 5:15 PM
(5-329) Polypharmacy and Potentially Significant Drug-Drug Interactions with Antiviral Therapy in Older Adults with HIV
Favorite
4:15 PM - 5:15 PM
(5-330) Use of Micafungin Monotherapy for Management of Candida Auris Endocarditis
Favorite
4:15 PM - 5:15 PM
(5-331) The Role of Cannabinoids in the Inhibition and Eradication of Biofilms Formed by PA14, a Clinical Isolate of Pseudomonas aeruginosa
Favorite
4:15 PM - 5:15 PM
(5-332) Enhancing Pediatric Pharmacy Resident Education Through Active Student Involvement
Favorite
4:15 PM - 5:15 PM
(5-333) Pharmacogenetic-based warfarin dosing in an urban indigent population: A Feasibility Study
Favorite
4:15 PM - 5:15 PM
(5-334) Advocacy for Pharmacist Provider Status Recognition; Comparative Evaluation and Patient Care Outcomes in Independent versus Chain Pharmacies
Favorite
4:15 PM - 5:15 PM
(5-335) Determinants of Accessibility to Essential Medicines in New York City by Zip Code Income Levels and Boroughs
Favorite
4:15 PM - 5:15 PM
(5-336) Pharmacists on the Digital Frontline: A Qualitative Study on Improving Telepharmacy Implementation, Communication, and Technology for Chronic Disease Management
Favorite
4:15 PM - 5:15 PM
(5-337) Vitamin D Supplementation: Addressing the appropriateness of prescribing and preventing toxicity
Favorite
4:15 PM - 5:15 PM
(5-338) Exploring the Coupled Epidermal Growth Factor Receptor E114K and Exon 19 Deletion Mutations in a Patient with Non-Small Cell Lung Cancer: A Case Report
Favorite
4:15 PM - 5:15 PM
(5-339) Effects of Cannabis Consumption on the Treatment and Management of Oral Health Disorders
Favorite
4:15 PM - 5:15 PM
(5-340) Effectiveness and Safety of Long-Acting Injectable Antiretroviral Therapy in Renal Impairment
Favorite
4:15 PM - 5:15 PM
(5-341) Assessment of Student Pharmacists’ Perceptions Regarding Transitions of Care: An Interim Analysis
Favorite
4:15 PM - 5:15 PM
(5-342) Does the cost incurred by the institution for inpatient use of Dificid (fidaxomicin) outweigh the benefit of Dificid (fidaxomicin) over oral vancomycin
Favorite
4:15 PM - 5:15 PM
(5-343) Successful treatment of chronic hepatitis C with glecaprevir/pibrentasvir and concomitant use of phenytoin
Favorite
4:15 PM - 5:15 PM
(5-344) The Unforeseen Consequences of Glycopyrronium Tosylate Cloths
Favorite
4:15 PM - 5:15 PM
(5-345) To Batch or Not to Batch: A Medication Use Evaluation of Ferric Gluconate
Favorite
4:15 PM - 5:15 PM
(5-346) Brushing Up on Antibiotic Stewardship: Pharmacy Students Survey and Educate Dentists on Antibiotic Prescribing Guidelines and Practices.
Favorite
